Abstract Presentations

Sunday, 4 December 2011

Sunday | Monday | Tuesday | Wednesday | top

12:30 - 14:00

Poster Symposium 1: Allied Health
Coral Gallery 3 (Fiesta Americana)
 Chairpersons: Connie Katelaris (Australia) , Dennis Ledford (US) and Birthe Dahl (Denmark)
12:30 - 13:15
Poster Viewing
13:15 - 00:00
1000: Reduction In Allergic Rhinitis Index by Decreasing Aero-Allergens and Malodor Causing Volatile Organic Compounds by Luna Air Purifiers Using Photo-Catalytic Oxidation (PCO) Technology | Nabarun Ghosh (US)
13:15 - 00:00
1001: The Missing Link!! Specialist Nurse-Led Education for Parents of Children with Atopic Eczema | Deryn Thompson (Australia)
13:15 - 00:00
1002: Sublingual Immunotherapy for Grass Pollen Allergy In Children: A Systematic Review and Meta-Analysis | Rebecca Bryson (United Kingdom)
13:15 - 00:00
1003: Effect of EPA-DHA Supplementation on Forced Expiratory Volume in One Second (FEV1) and Triglycerides in Obese Adolescents with Hypertriglyceridemia | Nancy Mendez Berreondo (Mexico)
13:15 - 00:00
1004: A Pilot Study of Caregiver's Recall of Their Child's Skin Test Results and Environmental Remediation Education | Kristen Townsend (US)
13:15 - 00:00
1005: Evaluation and Comparison of Lung Function by Plethysmography In Adolescents with Morbid Obesity, Not Morbid Obesity and Healthy Eutrophic Children | Luis Octavio Hernandez-Mondragon (Mexico)
13:15 - 00:00
1006: Delivering An Educational Model for Allergy Immunotherapy | Claire Murphy (US)
13:15 - 00:00
1007: Selecting Primal Therapy Appropriate for the Type of Pollinosis – TOPIC-J Study | Kimihiro Okubo (Japan)
13:15 - 00:00
1008: Olfactory Disfunctions in Patients with Chronic Rhinosinusitis | María Victoria Sánchez Vallecillo (Argentina)
13:15 - 00:00
1009: Perceptions of Caregivers of Patients with Cow's Milk Allergy Regarding the Treatment Antônio Carlos Pastorino (Brazil)
13:15 - 00:00
1010: Incidence of Systemic Reactions (SRs) to Prick (P) and Intradermal (ID) Tests, Response to Immediate (“Stat”) Epinephrine IM (epi IM) Dose Vs. BMI, Number of Delayed SRs, and WAO Systemic Reaction Grade | Dona Shearer (US)
13:15 - 00:00
1011: The “Allergy Blog” and Laypersons Questions: An Interactive Educational Experience | Jose Luiz Rios (Brazil)
13:15 - 00:00
1012: Anaphylaxis After Anesthetic Reversal | Sendy Chugo (Spain)
13:15 - 00:00
1013: Establishment of Reference Values for Differential Cell Counts in Nasal Lavage of Healthy Young Adults Jing Li (China)

Monday, 5 December 2011

Sunday | Monday | Tuesday | Wednesday | top

12:15 - 14:15

Poster Session 1: Asthma and Co-Morbid Conditions
Poster Hall (Cancún Center)
2000
Screening for Allergic Bronchopulmonary Aspergillosis in Patients with Aspergillus + Asthma From 2000-2010 | Paul Greenberger (US)
2001
Sleep-Disordered Breathing in Obese and Eutrophic Adolescents, Asthmatics and Not Asthmatics, in the Hospital Infantil of Mexico Federico Gómez | Alexander Morales (Mexico)
2002
Dyspnea in Chronic Fatigue Syndrome (CFS): Comparison of Two Prospective Cross-Sectional Studies James Baraniuk (US)
2003
Proteomics of Induced Sputum in COPD, Healthy Smokers and Chronic Bronchitis James Baraniuk (US)
2004
Incidence of Allergy In Patients with Benign Lesions of the Vocal Cords: Preliminary Report Ustun Osma (Turkey)
2005
Echocardiographic Findings In Obese Adolescents with and without Asthma | Lizette Montejano-Elías (Mexico)
2006
Asthma Prevalence and Body Mass Index in Children | Olf Herbarth (Germany)
2007
Evaluation and Comparison of Lung Volumes and Capacities In A Group of Morbid Obese, Obese and Eutrophic Adolescents | Jeannette Mendiola Marin (Mexico)
2008
Difficult-to-Treat Asthma with Idiopathic Chronic Eosinophilic Pneumonia | Norbert Pauk (Czech Republic)
2009
Diagnosis and Management of Post-Radiation Pneumonitis In Patients with Asthma Kostas N. Syrigos (Greece)
2010
Pathogenesis of Radiation-Induced Pneumonitis In Patients with Chronic Obstructive Pulmonary Disease Ekaterini Syrigou (Greece)
2011
Medication Responses in Chronic Fatigue Syndrome (CFS) and Non-CFS Subjects James Baraniuk (US)
2012
Psychogenic Intractable Sneezing. Case Report Karla Mejia (Mexico)
2013
Clinical Investigation of Cough Associated with or without Cough-Variant Asthma or Bronchial Asthma In the Outpatient Cases Including Pertussis, Chlamydophilia Pneumoniae Bronchitis, and Mycoplasma Pneumoniae Bronchitis | Hirokazu Nakajima (Japan)
2014
GERD Screening by the Use of F-Scale and Allergy Screening for Diagnosis and Treatment of Chronic Cough | Ryuichi Nishihira (Japan)
2015
Diagnosis of Gastroesophageal Reflux Disease in Patients with Chronic Cough | Rosana Camara Agondi (Brazil)
2016
Botox Injections in Larynx As a Treatment for Vocal Cord Dysfunction | Juan Esteban Perez (US)
2017
The Importance of Recognizing Vocal Cord Dysfunction in the Presence of Allergy and Asthma | Karine Issa-El-Khoury (Canada)
2018
Myasthenia Gravis and Asthma, Relationship Between Two Different Disorders of the Immune System | Andrea Aida Velasco-Medina (Mexico)
2019
Immunological Characteristics of PATIENTS with Bronchial Asthma and Obesity | Anna Konischeva (Russia)
2020
Association Between Body Mass Index, Asthma Severity and Quality of Life in Allergic Asthmatic Adults | Jose Antonio Olvera-Marquez (Mexico)
Poster Session 2: Pediatric Asthma
Poster Hall (Cancún Center)
2021
Not All Who Wheeze Have Asthma - Tracheal Diverticulum with Stenosiis of Trachea In 9 Years Old Boy | Frantisek Kopriva (Czech Republic)
2022
Reccurent Wheezing in Childhood - Is It Always Asthma? | Andrea Daniela Muti (Romania)
2023
Bronchial Hyperresponsiveness In Children with Suggestive Asthma Symptoms | Silvia Sanchez-Garcia (Spain)
2024
Relationship Between Fractional Exhaled Nitric Oxide (FeNO) and Forced Expiratory Volume in One Second (FEV1) and Forced Vital Capacity (FVC) in Children with Asthma | Myung-Sung Kim (South Korea)
Poster Session 3: Pediatric Asthma Epidemiology
Poster Hall (Cancún Center)
2025
Evaluation of the September Epidemic of Asthma Exacerbation in Children in Our Practice | Agnes Nemeth (Hungary)
2026
Elevated Asthma Prevalence in Mexican-American Children in El Paso TX | Alma Ruiz-Payan (US)
2027
Prevalence of Bronchitis and Revealing of the Risk Factors in the Children's Population | Nino Adamia (Georgia)
2028
Atopic Phenotype In Children Under 6 Years with Persistent Wheezing In El Salvador | Mauricio Flores (El Salvador)
2029
Comparison of Exhaled Nitric Oxide and Spirometry in Hispanic/Latino Children Living in Miami to Those Living in Latin America | Miguel J Lanz (US)
2030
Maximum Expiratory Flow in Health Children From the Metropolitan Area of Monterrey Mexico | Dora Valdes (Mexico)
2031
Sensitization to Mites. Relation with Atopic Diseases In School Children From San Antonio De Los Baños | Alexander Diaz Rodriguez (Cuba)
2032
Clinical and Immunological Findings in Childhood Asthma | Andrea Daniela Muti (Romania)
2033
Prevalence of Bronchial Asthma in Rural Indian Children: A Cross Sectional Study From South India | Animesh Jain (India)
2034
Viral Respiratory Infections and the Development of Atopy and Asthma | Cissy B Kartasasmita CB (Indonesia)
2035
Clinical Characteristics of Eosinophilic Asthma Compared to Noneosinophilic Asthma in Children | Yong Ju Lee (South Korea)
Poster Session 4: Aerobiology
Poster Hall (Cancún Center)
2036
Connections in Health-Web 2.0, Tele-Aerobiology, Through a Global Allergy Database | Dan Dalan (US)
2037
Thunderstorm-Related Asthma in Patients Sensitised to Olea Europaea Pollen: Twenty Emergency Department Visits for Asthmatic Symptoms in One Single Day | Laura Losappio (Italy)
2038
The Revised Edition of Korean Calendar for Allergenic Pollens | Jae-won Oh (South Korea)
2039
Aerobiological Study of Anemophilous Pollens in the City of Toluca, Mexico | Maria Cid del Prado - Izquierdo (Mexico)
2040
Allergenic Significance of Airborne Rhizopus Stolonifer (Ehrenb.) Vuill., a Common Bread Mold | Gaurab Sircar (India)
2041
Aerobiological and Immunological Studies On Coconut Pollen Allergy | Bodhisattwa Saha (India)
2042
Sensitization to Casuarina Equisetifolia and Pinus Spp Pollen In A Group of Mexican Patients | Andrea Aida Velasco-Medina (Mexico)
2043
PATTERNS of Skin Prick Test Positivity In 519 PATIENTS with Allergic Rhinitis and Asthma In Mexico CITY | Karla Paola Ruiz Cervantes (Mexico)
2044
Risk Factors and Their Impact On Development and Severity of Allergic Diseases In the CIS-Region | Tatiana Slavyanskaya (Russia)
2045
Monitoring of AIR-Pollutants Concentration In CHILDREN with ALLERGIC DISEASES | Manana V. Chikhladze (Georgia)
2046
Analysis of An After-Care Questionnaire In Allergic People to Dust Mites Using Anti-Dust Mites Bed Covers | Nabile Boukhettala (France)
2047
Changing Scenario of Airborne Allergens in Bangalore India | Anand Pendakur (India)
Poster Session 5: Mechanisms of Asthma and Allergic Inflammation
Poster Hall (Cancún Center)
2048
Human Mononuclear Phagocytes Are Regulated by A Cross-Talk with Epithelial Cells | Ilja Striz (Czech Republic)
2049
Activation of PAR-2 Induces Myofibroblast Transformation Via a TGF-β and GSK-3β/β-Catenin Dependent Pathway in Tissue Remodeling in the Asthmatic Lung | Tomoko Suzuki (Japan)
2050
Investigating the Role of IL-4 Receptor Alpha Signalling Through CD4+ T Cells in Ovalbumin-Induced Allergic Airway Disease | Jaisubash Jayakumar (South Africa)
2051
CD70-CD27 Interaction Regulates Asthmatic Response in a Murine Model of Asthma | Fumihiko Makino (Japan)
2052
Plasminogen Activator Inhibitor-1, Fibrinogen and Lung Function In Adolescents with Asthma and Obesity | Fengyang Huang (Mexico)
2053
Increased Surfactant Protein-D In Young Infants with Bronchiolitis | Hai Lee Chung (South Korea)
2054
Peculiarities of Immune Response In Young Children with Recurrent Wheezing | Olga Gromadina (Russia)
2055
Participation of Invariant NKT Cells (Vα24Jα18) During Asthma Exacerbation in Children | Juan Carlos Carpio-Pedroza (Mexico)
2056
Dexamethasone Can Reverse the Alteration of Airway Epithelial Responses to Rhinovirus Infection by Th2 Cytokines | Min-Suk Yang (South Korea)
2057
Cytokine Profile Characterization in Patients Infected with AH1N1 Influenza Virus Atzin Robles-Contreras (Mexico)
2058
Basal T Cell Subpopulations of Normal Humans Vary by Stress Hormone Receptor Polymorphisms Gailen Marshall (US)
2059
The Protective Effects of Exogenous IGFBP-3 on Allergic Airway Inflammation Through Blockade of VEGF Production | Seung Yong Park (South Korea)
2060
Antioxidants Attenuate Airway Remodeling by Regulating NF-ÊB, Nrf2, and HIF in a Murine Model of Chronic Asthma | Seoung Ju Park (South Korea)
2061
CCL3L1 protein did not affect IL-6 expression, but significantly up-regulated IL-10 expression in the allergic response | Byoung Whui Choi (South Korea)
2062
Caspase-9 Is Involved in CD30 Activation Induced Eosinophil Apoptosis | Jin Tack Kim (South Korea)
2063
Role of NLR (nucleotide oligomerization domain(NOD) – like receptor) on allergic inflammation in a mouse model of allergic rhinitis | Soo Whan Kim (South Korea)
2064
Mutant IL-3: A Common Down Regulator for Components of IgE Mediated Signal Transduction Pathway | Anand Singh (India)
2064A
IL-17 Role in the Regulatory Function of B Cells | Alejandro Vazquez-Tello (Saudi Arabia)
2064B
Role of Th-17 Cytokines in Steroid Insensitivity in Peripheral Blood Mononuclear Cells. Relationship to GR-Alpha and GR-Beta Expression | Alejandro Vazquez-Tello (Saudi Arabia)
Poster Session 6: Allergy to Antimicrobials
Poster Hall (Cancún Center)
2065
Penicillin Allergy Evaluation: Experience From a Drug Allergy Clinic in Kuwait | Mona Al-Ahmad (Kuwait)
2066
Association Between Genetic Polymorphisms of ABCC2 Transporter and the Susceptibility to Maculopapular Eruption Induced by Antituberculosis Drugs | Sang-Hoon Kim (South Korea)
2067
The Real Use of Beta-Lactams After "Penicillin Allergic" Label Removal | Shai Cohen (Israel)
2068
Hypersensitivity to Beta-Lactam Antibiotics Evaluation Using the European Network Drug Allergy (ENDA) Algorithm José Luiz Rios (Brazil)
2069
Clinical Features of Drug Rash with Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculous Medications | Sang-Ha Kim (South Korea)
Poster Session 7: Drug Allergy 1
Poster Hall (Cancún Center)
2070
Non-Steroidal Anti-Inflammatory Drugs Hypersensitivity: Patterns of Reaction | Luis Felipe Chiaverini Ensina (Brazil)
2071
Epidemiology of Immediate Type Adverse Drug Reactions and Rashes Elicited by NSAID | Tamar Kinaciyan (Austria)
2072
Test In Vitro to Investigate the Cytotoxicity and Cellular Nonspecific Stimulation of Basophils with Indomethacin | Zamir Calamita (Brazil)
2073
Aspirin Desensitization Treatment : A Case Report | Mirta Alvarez (Cuba)
2074
Adverse Drug Reactions to Anti-Asthmatics In Patients with Bronchial Asthma | Cheol-Woo Kim (South Korea)
2075
Presentation of Three Cases of Allergic Reactions to Triptorelin | Maria Cristina Diaz (Argentina)
2076
Adverse Drug Reactions in Hospitalized Patients Pedro Giavina-Bianchi (Brazil)
2077
An Unusual Reaction to Intravenous Iron Sucrose | Michael Balduzzi (US)
2078
Urticaria and Arthralgias In a Nine-Year-Old with Recurrent Urinary Tract Infections | Ahmed Butt (US)
2079
Jessner-Kanoff Lymphocytic Infiltrate As a Side Effect of Immunotherapy | Arzu Didem Yalcin (Turkey)
2080
Improvement of Oral Lichenoid Reaction Symptoms After Removal of Amalgam Restorations: An Anusual Case of Type IV Hypersensitivity Oguzhan Yildiz (Turkey)
2081
Hypersensitivity Reactions to Interferon Based Treatment for Hepatitis C: A Single Center 20-Year Experience | Ioannis Sidiropoulos (Greece)
Poster Session 8: Food Allergy
Poster Hall (Cancún Center)
2082
Effect of Hydrolysis and Polymerization on Bovine Beta-Lactoglobulin Immunoreactivity | Mariana Battaglin Villas-Boas (Brazil)
2083
Immunoreactivity of Polymerized and Digested Beta-Lactoglobulin to IgE From Milk Allergic Patients | Mariana Battaglin Villas-Boas (Brazil)
2084
Identification of Novel Allergens in the Fish Parasite Anisakis Simplex Maaike Dooper (Norway)
2085
Milk Components As a Tool in Predicting Tolerance in Cow's Milk Allergy Ana Paula Beltran Moschione Castro (Brazil)
2086
Uncommon Occupational Allergy to Rice: As a Food Allergen | María Socorro Pérez-Bustamante (Spain)
2087
Frequency of Food Hypersensitivity Mediated by IgG in Patients Received in a Venezuelan Laboratory During 2011 | Cristina Najm (Venezuela)
2088
IgE-Mediated Responses towards Fish Parasite Anisakis, Crab and House Dust Mite in Norwegian Shrimp Allergic Individuals | Maaike Dooper (Norway)
Poster Session 9: Food Allergy: Epidemiology
Poster Hall (Cancún Center)
2089
Patterns of Sensitization to Common Food and Inhalant Allergens and Allergic Symptoms in Preschool Children | Man Yong Han (South Korea)
2090
Food Allergy Prevalence and Symptomatology in Inner City African Americans: A Retrospective Study | Mario Rodenas (US)
2091
PREVALENCE of FOOD Allergy In ADULT PATIENTS of SERVICE Allergy and CLINICAL Immunology – Centro Medico Nacional Siglo XXI - IMSS Mexico DF | Nelva Guillén (Mexico)
2092
Sensitization to Food Allergens in Patients of the Allergy Service of the University Hospital of Monterrey, Mexico | Luis Dominguez (Mexico)
2093
Frequency of Food-Sensitization by Prick-to-Prick Test and Atopy Patch Test In Allergic Children | Jonathan Maya (Mexico)
2094
Increasing Incidence of Food Allergy In Zimbabwe | Elopy Sibanda (Zimbabwe)
2095
Ten Years Follow up of Japanese Survey on Immediate Type Food Allergy | Takanori Imai (Japan)
2096
Association Between Cows Milk Allergy and Gastroesophageal Reflux Disease on Mexican People | Fernando Ramirez Jimenez (Mexico)
2097
An Investigation of Food Choice Behaviour of Food Allergic and Non-Food Allergic Children | Isolde Sommer (United Kingdom)
Poster Session 10: Incidence and Prevalence of Food Allergy
Poster Hall (Cancún Center)
2098
Nationwide Survey of Immediate Type Food Allergy in Japan | Takanori Imai (Japan)
2099
The Prevalence of Food Allergy in Children Under 2 Years in Three Cities in China | Jing Chen (China)
2100
Skin Sensitization to Carmine Before Onset of Systemic Allergy to Ingested Carmine | Yoshinori Katada (Japan)
2101
Milk, the Most Commonly Undeclared Food Allergen Causing Unexpected Allergic Reactions in Sweden Between 2004 and 2011 Ylva Sjogren-Bolin (Sweden)
2102
Cross Sectional Study of 1,822 Pediatric Food Allergy Patients | Takatsugu Komata (Japan)
2103
Surface Plasmon Resonance Imaging: New Tool for Immunodiagnostics of Food Allergy | Oussama Abou Chakra (France)
Poster Session 11: Food Allergy: Gastrointestinal Manifestations
Poster Hall (Cancún Center)
2104
Probiotic Effect of the Regulation of Innate Immune Response, DC and Adaptive Cellular Immune Response and the Balance TH1, TH2, TREG Through Sensors TLR-2 and TLR-4, On the Intestinal Mucosa In Balb/c Health Status and Balb/c Status of Exposure to LPS | Azwin Lubis (Indonesia)
2105
Gluten Induced Systemic Disease (GISD) with Distinct Clinical Phenotype Different From Celiac Disease | Nataliya M. Kushnir (US)
2106
Patterns of Food Allergens in Kenyan Children | Rose Kamenwa (Kenya)
2107
Coincidence of Celiac Disease and Gluten Allergy | Katarzyna Markiewicz (Poland)
2108
Immunoreactivity of ß-Lactoglobulin and Identification of the Peptides Generated After Simulated Orogastrointestinal Digestion Iván López-Expósito (Spain)
Poster Session 12: IgE
Poster Hall (Cancún Center)
2109
Levels of IL-4, INF-γ, Total IgE and IgG4 in Serum of Allergic Children within Areas of Risk of Lead Exposure in Torreon Coahuila, Mexico | Karen Giselle Chavez Villarreal (Mexico)
2110
Relationship of Blood Lead Levels with Total IgE in Teenagers with Environmental Exposure in Torreon Coahuila, Mexico | Rocío Meza-Velazquez (Mexico)
2111
IgE From Birch Pollen Allergic Patients Cross-Reacts with Two Distinct Bet v 1 Related Proteins in Mung Beans: Vig r 1 and Cytokinin-Specific Binding Protein | Eva Guhsl (Austria)
2112
Heterogeneity of the IgE Response to Allergenic Determinants of Cefotiam in Serum Samples From Patients with Cefotiam–Induced Occupational Allergy | Jeong-Eun Kim (South Korea)
2113
Evaluating Total Serum IgE Levels in Patients with Chronic Hepatitis B and C | Sükran Köse (Turkey)
2114
Relationship Between Total Serum IgE, Atopy, and Obesity in Children with or without Family History of Atopic Disease | Budi Setiabudiawan (Indonesia)
2115
The Candidate Peptides in IgE for Allergy Vaccine Design | Gholam Ali Kardar (Iran)
Poster Session 13: Anti-IgE
Poster Hall (Cancún Center)
2116
REFRACTORY CHRONIC Urticaria Treated with Omalizumab | Martinez Saenz (Mexico)
2117
Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy | Arzu Didem Yalcin (Turkey)
2118
Evaluation of Adverse Events Associated to Administration of Omalizumab | R Maximiliano Gomez (Argentina)
2119
Gender and Different Prevalence in Asthma Treatment with Anti-IgE (omalizumab) | Vincenzo Patella (Italy)
2120
Fetal Loss in Severe Asthma and Posterior Healthy Pregnancy and Birth with the Use of Omalizumab - Case Report | Fábio Kuschnir (Brazil)
2121
Vasculitic Urticaria Treated with Omalizumab. Case Report | María Elena Ramírez Del Pozo (Mexico)
2122
Efficacy of Omalizumab in the Treatment of Urticaria-Vasculitis Associated to Churg-Strauss Syndrome: A Case Report Massimo Triggiani (Italy)
2123
A 4-Year Follow-up in Children with Moderate/Severe Asthma After Withdrawal 1 Year Omalizumab Treatment | Alvaro Teijeiro (Argentina)
2124
Serum Soluble TRAIL Levels In Patients with Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment | Arzu Didem Yalcin (Turkey)
2125
Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations In Patients with Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment | Arzu Didem Yalcin (Turkey)
2126
Near-Fatal Asthma Treated with Omalizumab | Elvia Angelica Contreras Contreras (Mexico)
2127
Use of Omalizumab In Chronic Moderate to Severe Persistent Asthma-An Indian Experience | Qamar Ansari (India)
2128
Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic | Jorge Vargas Correa (Mexico)
Poster Session 14: Immunotherapy
Poster Hall (Cancún Center)
2129
Allergen Standardisation in Allergens and Allergoids – Challenges and Considerations Alan Bullimore (United Kingdom)
2130
Development of In-House References of House Dust Mite Allergen Vaccines | Arelis Más Quintero (Cuba)
2131
Therapeutic Effect and Safety of Tropical Mite Allergen Vaccines by Subcutaneous Route in Allergic Asthmatics Patients | Raúl Lázaro Castro Almarales (Cuba)
2132
Therapeutic Effect and Security in Asthmatics Adults Patients Treated with Dermatophagoides Pteronyssinus Allergen Sublingual Immunotherapy | José Rodríguez (Cuba)
2133
Safety of Sublingual Immunotherapy with Standardized Vaccines of Domestic Mites | Mirta Alvarez (Cuba)
2134
The Effect of Specific Immunotherapy On the Clinical Response In Patients with Grass-Polen Induced Rhinoconjunctivitis | Zoran Arsovski (Macedonia)
2135
Does Sublingual Immunotherapy Work with an Immune Deviation Mechanism? Francesco Marcucci (Italy)
Poster Session 15: Hymenoptera Allergy
Poster Hall (Cancún Center)
2136
When Honeybees Attack: Adrenal Insufficiency as a Late Consequence of Massive Exposure | David Robinson (US)
2137
Efficacy of Immunotherapy with Allergenic Extract of Aedes Aegypti in the Treatment of Large Local Reaction to Mosquito Bites in Children | Maria Amelia Manrique (Mexico)
2138
Specific Venom IgE Decrease During 5 Years of Venom Immunotherapy (VIT): Clinical Relevance in Stung and Not Stung Patients | Valerio Pravettoni (Italy)
2139
Skeeter Syndrome a Case Report and Literature Review | Diego Garcia-Calderin (Mexico)
2140
Bee Venom Immunotherapy with Standardized Extract, Two Case Comunication and Clinical Progress | Aristoteles Alvarez Cardona (Mexico)
2141
Clinical Case. Bee Venom Anaphylaxis | Adriana Barreto-Sosa (Mexico)
2142
Urticarial Vasculitis AFTER Bee-STING THERAPY | June-Hyuk Lee (South Korea)

12:45 - 14:15

Oral Abstract Session 1: Allergen Immunotherapy 1
Gran Cancún 1 (Cancún Center)
 Chairpersons: Noel Rodriguez-Perez (Mexico) and Enrico Compalati (Italy)
12:45 - 13:00
2156: Ultra-Rush Specific Immune Therapy with Depigmented and Polymerized Allergen Extracts Is Effective and Safe in Patients with Severe SAR Highly Sensitized Against Pollen Allergens Ulrich Amon (Germany)
13:00 - 13:15
2157: Dose Optimizing Study of A Depigmented Polymerized Allergen Extract of Birch Pollen by Means of Conjunctival Provocation Test | Angelika Sager (Germany)
13:15 - 13:30
2158: Double-Blind Study on The Use of Transfer Factor (TF) Combined With Sublingual Immunotherapy in Management of Patients With Allergic Rhinitis in Mexican Population | María Isabel Rojo Gutiérrez (Mexico)
13:30 - 13:45
2159: The Risk of Severe Treatment Related Adverse Events is Significantly Lower in Children Compared to Adults when Treated With Standardised Timothy Grass Allergy Immunotherapy Tablets: Post Hoc Analysis of 7 Clinical Trials | Jens Strodl Andersen (Denmark)
13:45 - 14:00
2160: Post-treatment, long-term clinical efficacy of a 300 IR sublingual tablet of 5-grass pollen allergen extract in adults with grass pollen-induced allergic rhinoconjunctivitis Michèle Lheritier-Barrand (France)
14:00 - 14:15
2161: Escherichia coli Heat-labile Enterotoxin (LTS61K) Modulates Dendritic Cell Function and Attenuates Airway Inflammation in Mouse Model of Allergic Asthma | Jiu_yao Wang (Taiwan)
Oral Abstract Session 2: Allergen Structure 1
Gran Cancún 2 (Cancún Center)
 Chairpersons: Enrique Fernandez-Caldas (Spain) and Oussama Abou Chakra (France)
12:45 - 13:00
2162: Comprehensive Detection of Allergens in Grass Pollen Extracts by Mass Spectrometry | Steffen Augustin (Germany)
13:00 - 13:15
2163: Gene Expression Pattern of Arabidopsis EXPB1, a Non-Allergenic Homologue of Grass Group 1 Pollen Allergens | Prem Bhalla (Australia)
13:15 - 13:30
2164: Comprehensive Expression of Recombinant House Dust Mite Allergens for Component-Resolved Diagnosis | Yoshiharu Watakabe (Japan)
13:30 - 13:45
2165: A Bioinformatic Approach to Allergen Nomenclature Applied to Allergens From the Non-Biting Midge Chironomus Thummi Thummi | Heimo Breiteneder (Austria)
13:45 - 14:00
2166: Pollen Allergens Differ From Non-Allergenic Pollen Proteins by Their Lower Extent of Evolutionary Conservation | Christian Radauer (Austria)
14:00 - 14:15
2167: Sensitization to Betula Verrucosa and Rbet v1 in Spain | Barbara Cases (Spain)
Poster Symposium 2: Asthma Treatment
Bacalar (Cancún Center)
 Chairpersons: Michael Schatz (US) and Paul O'Byrne (Canada)
12:45 - 13:30
Poster Viewing
13:30 - 00:00
2143: Reduction in Asthma Deteriorations in Subjects with Persistent Asthma Not Well Controlled on Low-, Medium-, or High-Dose Inhaled Corticosteroids: A Pooled Analysis From Three Clinical Trials Using Combined Mometasone Furoate/Formoterol | Steven Weinstein (US)
13:30 - 00:00
2144: Efficacy Comparison of Mometasone Furoate/Formoterol Versus Fluticasone Propionate/Salmeterol Combination Therapies in Subjects with Persistent Asthma: Noninferiority and Onset-of-Action Findings Hendrik Nolte (US)
13:30 - 00:00
2145: Efficacy and Safety of Two Doses of Mometasone Furoate/Formoterol Combination Treatment in Subjects with Severe Asthma | Steven Weinstein (US)
13:30 - 00:00
2146: Effect of Mometasone Furoate/Formoterol Combination Therapy on Nocturnal Awakenings in Subjects with Persistent Asthma Hendrik Nolte (US)
13:30 - 00:00
2147: Quality of Life Improvements in Persistent Asthma Subjects Receiving Combined Mometasone Furoate and Formoterol Hendrik Nolte (US)
13:30 - 00:00
2148: Efficacy and Safety of Combined Mometasone Furoate/Formoterol 100/10ìg Twice Daily in Subjects with Asthma Inadequately Controlled on Low-Dose Inhaled Corticosteroids | Eli Meltzer (US)
13:30 - 00:00
2149: Prevalence of Swallowing Dysfunction in Severe Asthma: Preliminary Results Adelmir Souza-Machado (Brazil)
13:30 - 00:00
2150: Small Airway Function Is Consistently Improved in Asthma Patients Treated with Mometasone Furoate Delivered by a Dry Powder Inhaler Ariel Teper (US)
13:30 - 00:00
2151: Influence of Montelukast on the State of Eosinophil Activation in Asthmatic Children | Valéria Botan (Brazil)
13:30 - 00:00
2152: The Impact of Administration of Leukotriene Receptor Antagonists, Pranlukast-EK to Infants with Bronchial Asthma | Norifumi Ogawa (Japan)
13:30 - 00:00
2153: Effectiveness of Montelukast In 60 Cuban Patients with Moderate and Severe Asthma and Rhinitis | Mirta Alvarez (Cuba)
13:30 - 00:00
2154: Effect of the Treatment with Montelukast In Asthmatic Patient | Roberto O. Aguila de la Coba (Cuba)
13:30 - 00:00
2155: The Effectiveness of Two Different Methods of Salbutamol Nebulization in Children with Asthma | Andrzej Emeryk (Poland)
Oral Abstract Session 3: Allergic Models of Inflammation
Gran Cancún 3 (Cancún Center)
 Chairpersons: Giovanni Melioli (Italy) and Harald Renz (Germany)
12:45 - 13:00
2168: Common and Rare Variation In the T Helper 2 Gene Pathway Predicts Allergic Asthma Phenotypes | Rebecca Slager (US)
13:00 - 13:15
2169: Role of Myeloid Derived Suppressor Cells in Asthma Srinivas Nagaraj (US)
13:15 - 13:30
2170: Mir-150 Suppresses Lung Inflammation In A Mouse Model of Experimental Asthma | Jia-Wang Wang (US)
13:30 - 13:45
2171: Serine Protease Inhibitor Attenuates OVA Induced Inflammation In Mouse Model of Allergic Airway Disease | Sanjay Saw (India)
13:45 - 14:00
2172: Potential Role of Scavenger Receptors in Human Mast Cell Cytokine Response to Oxidized LDL Francesca Levi-Schaffer (Israel)
Oral Abstract Session 4: Allergic Rhinitis
Gran Cancún 4 (Cancún Center)
 Chairpersons: Mark Dykewicz, MD (US) and Yeong Ho Rha (South Korea)
12:45 - 13:00
2173: Allergic Rhinitis to Ragweed Pollen | Ioana Corina Bocsan (Romania)
13:00 - 13:15
2174: Ragweed Allergy – What Role Does It Play in Bavaria? | Mareike McIntyre (Germany)
13:15 - 13:30
2175: Nasal Nitric Oxide and Nasal Polyposis As Determinants of Asthma Control | Enrico Heffler (Italy)
13:30 - 13:45
2176: Peak Nasal Inspiratory Flow Levels In Children with Allergic Rhinitis and Their Health Related Quality of Life (HRQL) | Major K. Nagaraju (India)
13:45 - 14:00
2177: Exhaled Nitric Oxide and Airway Function in Seasonal Allergic Rhinitis | Masanobu Shinogami (Japan)
Oral Abstract Session 5: Atopic Dermatitis 1
Gran Cancún 5 (Cancún Center)
 Chairpersons: Prof. Dr. Peter Schmid-Grendelmeier (Switzerland) and Atsuo Urisu (Japan)
12:45 - 13:00
2178: Contribution of IL-33 and Nuocyte to Experimental Allergic Dermatitis | Yasutomo Imai (Japan)
13:00 - 13:15
2179: S100A8/A9, A DAMP Molecule Activated by IL-17 and House Dust Mite Is Upregulated In Atopic Dermatitis Kwang Hoon Lee (South Korea)
13:15 - 13:30
2180: Arginase I Levels Are Decreased In Pediatric Patients with Atopic Dermatitis | Victoria Dimitriades (US)
13:30 - 13:45
2181: Polyprenol Could Prevent Loss of Filaggrin In Epithelial Cells In Atopic Dermatitis | Ivans S Kuznecovs (Latvia)
13:45 - 14:00
2182: Role of Sweating On Impaired Skin Barrier Functions In Atopic Dermatitis | Aya Takahashi (Japan)
14:00 - 14:15
2183: Reduced Occurrence of Early Atopic Dermatitis Due to Immunoactive Prebiotics Among Low Atopy Risk Infants | Christoph Grüber (Germany)
Oral Abstract Session 6: Conjunctivitis
Cozumel 2 (Cancún Center)
 Chairpersons: Sergio Bonini (Italy) and Leonard Bielory (US)
12:45 - 13:05
: Test Title
13:05 - 13:20
2184: Ocular Signs and Symptoms Elicited by a Naturalistic Allergen Challenge in An Environmental Exposure Chamber Model Versus a Direct Allergen Instillation Model | Michael S. Blaiss (US)
13:20 - 13:35
2185: Increased Frequency of CD4+ CD25+ FOXP3- in Allergic Conjunctivitis Patients | Jorge Galicia-Carreón (Mexico)
13:35 - 13:50
2186: Increased Frequency of CD4+ CCR4+ CCR9+ Cells in Patients with Allergic Conjunctivitis | Miguel E Alonso-Sánchez (Mexico)
13:50 - 14:05
2187: Long-Term IFN-g Treatment Alters Allergic Inflammation-Associated Gene Expression in Conjunctival Fibroblasts | Naoko Okada (Japan)
14:05 - 14:20
2188: Hyperosmolar Conjunctival Provocation Test (HCPT) in the Evaluation of Ocular Symptoms Nelson Rosario (Brazil)
14:20 - 14:35
2189: Tear IFN-g Is Increased After Sublingual Immunotherapy in Allergic Conjunctivitis Patients and Correlates with Clinical Improvement | Gustavo Aguilar-Velazquez (Mexico)
Oral Abstract Session 7: Immunodeficiency
Isla Mujeres (Cancún Center)
 Chairpersons: John Sleasman (US) and Mark Ballow (US)
12:45 - 13:00
2190: Anxiety and Depression in Patients with Variable Common Immunodeficiency in the Service of Allergy and Clinical Immunology - Centro Médico Nacional Siglo XXI | Nelva Guillén (Mexico)
13:00 - 13:15
2191: Transient Immune Reconstitution Following Gastric Bypass Surgery with Ensuing Sjogren's Syndrome | John Kim (US)
13:15 - 13:30
2192: Computed Tomography Findings Consistent with Rhinosinusitis, Clinical Correlation and Quality of Life in Patients with Common Variable Immunodeficiency. Original Article | Elizabeth Mendieta (Mexico)
13:30 - 13:45
2193: Subcutanous Vivaglobulin® Replacement Therapy in Patients with Primary Immunodeficiency Confers Protective Antibody Titers to Major Organisms | Doanh Nguyen (US)
13:45 - 14:00
2194: Case Report: Recurrent Mucocutaneous Candidiasis and Recurrent Diarrhea by Gram Negative Bacteria | Juan Aldave Becerra (Peru)
14:00 - 14:15
2195: Bronchiectasis: Localization and Characteristics, Identified by Using a High Resolution CT Scan in Adults with Common Variable Immunodeficiency | Laura Mendoza (Mexico)
Oral Abstract Session 8: Indoor Risk Factors for Asthma
Tulum (Cancún Center)
 Chairpersons: Thomas Platts-Mills (US) and Myron Zitt (US)
12:45 - 13:00
2196: The Relationship of Pets, Vitamin D and IgE Concentrations to Upper Respiratory Infections In the First Year of Life | Dennis Ownby (US)
13:00 - 13:15
2197: Prevalence of Cockroach and Mouse Sensitization Among Children Hospitalized for Wheezing and Asthma | Terri Moncrief (US)
13:15 - 13:30
2198: Is Pet Ownership Associated with Higher Vitamin D? | Christine Cole Johnson (US)
13:30 - 13:45
2199: Sick Building Syndrome (SBS) Among Workers of Two Buildings and Exposure to Indoor Fungal Allergens in Rio De Janeiro, Brazil | Jose Laerte Boechat (Brazil)
13:45 - 14:00
2200: Asthma Among Office Workers and Exposure to Chemical and Biological Indoor Pollutants Jose Laerte Boechat (Brazil)
14:00 - 14:15
2201: Taxonomic Identification of the House Dust Mites Associated to Allergic Patients In Six Locations From Mexico | Naomi Cuervo (Cuba)
Oral Abstract Session 9: Mechanisms of Asthma
Xcaret (Cancún Center)
 Chairpersons: Daniel Jackson (US) and Bradley Undem (US)
12:45 - 13:00
2202: EGCG Down-Regulates Mucin Gene Expression Through the MAPK Signaling Pathway in Asthma | Yong-Dae Kim (South Korea)
13:00 - 13:15
2203: Enhancer of Zeste Homolog 2: A Pivotal Role in Pulmonary Artery Smooth Muscle Cell Proliferation | Salman Aljubran (US)
13:15 - 13:30
2204: The Features of Airway Remodeling Are More Severe in Female Mice | Masahide Takeda (Japan)
13:30 - 13:45
2205: Ovalbumin-Induced Bronchial Asthma Is Compromised in Apoptosis Signal-Regulating Kinase-Deficient Mice | Junichiro Mizuguchi (Japan)
13:45 - 14:00
2206: Role of the CC−Chemokine Receptor CCR9 In the Regulation of Inflammatory Process During Allergic Airway Inflammation | Cynthia López-Pacheco (Mexico)
14:00 - 14:15
2207: Serum IL6 and Soluble IL6R Are Correlated with Lung Function In Non-Hispanic Whites with Asthma | Gregory Hawkins (US)
Oral Abstract Session 10: Sublingual Immunotherapy 1
Costa Maya 1 (Cancún Center)
 Chairpersons: Moises Calderon and Peter Creticos (US)
12:45 - 13:00
2208: Safety and Dose-dependent Efficacy of a Novel Ragweed Allergen Immunotherapy Tablet in North American and European Patients: Preliminary Findings | Hendrik Nolte (US)
13:00 - 13:15
2209: Economic Evaluation of Grass Tablets for Immunotherapy (Oralair) Compared to Placebo in Adults and Children in Italy | Amerigo Cicchetti (Italy)
13:15 - 13:30
2210: The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablets in Adults with Allergic Rhinitis | Karl-Christian Bergmann (Germany)
13:30 - 13:45
2211: Efficacy of Immnunotherapy with An Oral Bacterial Lysate and Vitamin C In the Primary Prevention of Acute Respiratory Tract Infections In Children Luciano Cortigiani (Argentina)
13:45 - 14:00
2212: Impact of Pollen Exposure on the Treatment Effect of Ragweed and Grass Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis: Preliminary Findings | Sandra Gawchik (US)
14:00 - 14:15
2213: Efficacy of Timothy Grass Allergy Immunotherapy Tablet (AIT) Treatment in Canadian Children and Adults with Grass Pollen-Induced Allergic Rhinoconjunctivitis (ARC) | Jacques Hebert (Canada)
Oral Abstract Session 11: Urticaria and Angioedema
Costa Maya 2 (Cancún Center)
 Chairpersons: David Lang (US) and Jonathan Bernstein (US)
12:45 - 13:00
2214: The Efficacy of Human Plasma-Derived C1-Inhibitor Concentrate Used for Prophylactic Treatment In Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency | Dorottya Csuka (Hungary)
13:00 - 13:15
2215: Pre-Procedural Administration of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INH-nf) for the Prevention of Hereditary Angioedema (HAE) Attacks After Medical, Dental, or Surgical Procedures David Mariano (US)
13:15 - 13:30
2216: Open-Label Use of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INH-nf) for the Treatment of Hereditary Angioedema (HAE) Attacks Marc Riedl (US)
13:30 - 13:45
2217: Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant | Maria Concetta Siani (Italy)
13:45 - 14:00
2218: Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2 Receptor Antagonist, in Patients with Hereditary Angioedema Due to C1-INH Deficiency | Konrad Bork (Germany)
14:00 - 14:15
2219: Assessment of Chronic Spontaneous Urticaria by Serum-Induced TNFα and MMP-9 Release | Sidsel Falkencrone (Denmark)

Tuesday, 6 December 2011

Sunday | Monday | Tuesday | Wednesday | top

12:15 - 14:15

Poster Session 16: Asthma
Poster Hall (Cancún Center)
3000
The Correlation of Cholesterol Lowering Statin Drugs and Worsening Asthma Control In Mild Persistent Asthmatics | Safa Nsouli (US)
3001
Studies On The Relationship Between Airway Inflammatory Responses In Patients With Asthma Or Not-Yet Onset Asthma And Air Pollution | Mariko Yamaura (Japan)
3002
The Relationship Between Maternal Atopy and Childhood Asthma | Salome Abbott (South Africa)
3003
Sensitization of Severe Allergic Asthma Patients Pedro Giavina-Bianchi (Brazil)
3004
Reference Values and Influencing Factors of Exhaled Nitric Oxide In Healthy Korean Adults | Min-Suk Yang (South Korea)
3005
Association of Feno with IgE Levels in Patients with Allergic Asthma | Joselit Torres (Venezuela)
3006
The Relationship of Fractional Exhaled Nitric Oxide(FeNO) and Acute Exacerbation of Childhood Asthma | Yeong Ho Rha (South Korea)
3007
Relationship Between Exhaled Nitric Oxide and Levels of Asthma Control in Asthma Patients Treated with Inhaled Corticosteroid | Ho Joo Yoon (South Korea)
3008
Relationship Between Aeroallergen Sensitization and Asthma Severity in Mexican Children | Blanca Maria Morfin-Maciel (Mexico)
3009
Association of Asthma and IgE Levels Elianny Chavez (Venezuela)
3010
The Method of Antigen Specific Damage of Leucocytes by Food Additives in Patients with Bronchial Asthma | Nadya Titova (Belarus)
3011
Effect of Ascorbic Acid on Aiway Hyperresponsiveness in Bronchial Asthma | Young S Hwang (South Korea)
Poster Session 17: Asthma Diagnostic Tools
Poster Hall (Cancún Center)
3012
Bronchial Hyperresponsiveness In Obese Adolescents | Gabriela Ramírez (Mexico)
3013
Development of a Questionnaire for the Assessment of Bronchial Hyperresponsiveness in Korea | Seong Yong Lim (South Korea)
3014
Clinical Analysis of Salbutamol Responsiveness After Acetylcholine-Induced Bronchoconstriction in Childhood Asthma | Tomio Kondo (Japan)
3015
Preoperative Cardiopulmonary Exercise Testing (CPET) In Severe Asthma Patients | Ekaterini Syrigou (Greece)
3016
Annual Change of Peak Expiratory Flow Rate in Asthma and COPD | Kwang HA Yoo (South Korea)
3017
Evaluation of Chest Computed Tomography in Patients with Asthma Pedro Giavina-Bianchi (Brazil)
3018
Exercise-Induced Airway Obstruction and Vitamin D Deficiency Enrico Heffler (Italy)
3019
Lung Age/Chronological Age Index As Indicator of Clinical Improvement or Severity in Asthma Patients | Maria Isabel Castrejon (Mexico)
3020
Transition From Cough Variant Asthma to Asthma with Reduced FEV1 | June-Hyuk Lee (South Korea)
Poster Session 18: Pathophysiology of Childhood Asthma
Poster Hall (Cancún Center)
3021
Involvement of IL-10 Gene Promoter Polymorphisms in the Susceptibility for Childhood Asthma Kyu-Earn Kim (South Korea)
3022
Serum NT-3 and NT-4 Levels Are Associated with Clinical Severity In Asthmatic Children Marta Rachel (Poland)
3023
Serum Levels of Human Chitinase-Like Protein YKL-39 but Not YKL-40 Was Lower in Childhood Asthma | Yuzaburo Inoue (Japan)
3024
Association Between Eosinophilic Airway Inflammation and Persistent Airflow Limitation in Asthmatic Children Hyun Hee Lee (South Korea)
Poster Session 19: Pediatric Asthma Treatment
Poster Hall (Cancún Center)
3025
Correlation Between Quality of Life and Treatment Adherence in Childhood Asthma | García Jessica (Mexico)
3026
Effect of Diet Supplementation with EPA-DHE On Pulmonary Function Tests and Metacholine Bronchial Challenge Test In Obese Mexican Children | Luisa Guadalupe Pineda-Bahena (Mexico)
3027
Use of Complementary and Alternative Medicines by Children Suffering From Asthma At Mangalore, India | Animesh Jain (India)
3028
Long-Term Follow up Outcomes of Early Intervention with Anti-Inflammatory Therapy in Patients with Asthma Under 2 Year-Old | Masanori Ikeda (Japan)
3029
Asthma Treatment May Be Useful to Treat Recurrent Wheezing In Infancy | Herberto Jose Chong Neto (Brazil)
3030
Safety and Inhaler Use with Mometasone Furoate Delivered Via Dry Powder Inhaler for Children with Persistent Asthma Ariel Teper (US)
3031
Effect of Asthma Clinical Pathway for Children in the Emergency Department: 2007 Vs. 2008 | Hyun Hee Kim (South Korea)
3032
Trans Oro Pharyngeal Spacer For Inhalers Hari Kishan (India)
Poster Session 20: Aeroallergen Sensitization
Poster Hall (Cancún Center)
3033
Fungal Sensitization and Its Relation to Asthma and Allergic Rhinitis in Children Aged 6-7 Years | Alexander Diaz Rodriguez (Cuba)
3034
Study on the Sensitization Rates to Airbone Pollen and Mold in Children Dae Hyun Lim (South Korea)
3035
Influence of Degree of Specific Allergic Sensitivity on Severity of Rhinitis and Asthma in Chinese Allergic Patients | Jing Li (China)
3036
Allergic Sensitization to Domestic Mites In Santo Domingo, Dominican Republic | Antonio Castillo (Dominican Republic)
3037
Prevalence Sensitizing to Most Common Allergens in Elderly in Western Mexico" | Martín Bedolla-Barajas (Mexico)
3038
Cross Reactivity Between Cypress Pollen and Plant Food in Queretaro, Mexico | Alejandra Medina-Hernández (Mexico)
3039
Study of the Allergenic Crossreactivity and Allergenic Composition of Dermatophagoides Pteronyssinus and Blomia Tropicalis | Barbara Cases (Spain)
3040
Ficus Benjamina Sensitization in Adult Patients with Rhinitis Claudia Gallego (Mexico)
3041
Identification and Statistic Analysis Related with Climatic Variability and Transportation of the Most Abundant Spores in Mexicali, Mexico | Silvia Ahumada (Mexico)
Poster Session 21: Dust Mite Allergy
Poster Hall (Cancún Center)
3042
Standardization and Characterization of Dust Mite Extracts Manufactured in the USA | Greg Plunkett (US)
3043
Detection of Der p 2 in the House Dust and Correlation with Mite Number in An Environmental Survey | Jaw-Ji Tsai (Taiwan)
3044
Daily Vacuum Cleaning Significantly Reduces House Dust Mite Allergen, Endotoxin and β-Glucan Content of Mattresses Rob Siebers (New Zealand)
3045
Differences in Indoor Allergen Quantification in Hispanic/Latino Children Living in Miami to Those Living in Latin America | Miguel J Lanz (US)
3046
House Dust Mite Fauna and Its Relationship to Allergen Skin Tests in Six Mexican States | Bárbara Isabel Ferández Duro (Cuba)
3047
Oral Mite Anaphylaxis Is Caused by Mite-Contaminated Okonomiyaki Mix in Japan | Kentaro Takahashi (Japan)
Poster Session 22: Testing for Sensitization
Poster Hall (Cancún Center)
3048
Utility of Component-Based Allergen Chip (ImmunoCAP ISAC®) in Diagnosis of Allergic Rhinitis | Joo Hyun Jung (South Korea)
3049
Prevalence of Skin Reactivity to Blomia Tropicalis Antigen in Patients with Respiratory Allergy At Hospital Universitario De Puebla | Erica Marisol Martínez Villegas (Mexico)
3050
Prevalence of Sensitization to Parietaria, Pinus, Cupressus and Morus Pollens in Patients From CRAIC | Liborio Rafael Leal-Garcia (Mexico)
3051
Prevalence of Skin Reactivity to Antigen Mus Musculus in Patients with Respiratory Allergy | Chrystopherson Caballero (Mexico)
3052
Atopy Patch Test to Aeroallergens Extracts Is Useful In Allergic Diseases Diagnosis When Skin Prick Test Is Negative | Rocio Tordecilla (Chile)
3052A
Is Nasal Provocation Test Useful In Selecting Allergen for Immunotherapy In Children? | Ilknur Bostanci (Turkey)
3053
Clinical and Laboratory Studies of the Fate of Intranasal Allergen Eija Yli-Panula (Finland)
3054
Effect of Enzymatically Modified Isoquercitrin, a Flavonoid, on Symptoms of Japanese Cedar Pollinosis | Toshio Tanaka (Japan)
3055
Prevalence of Allergen Sensitization In Children with Atopy Suspicion Between Six Months and Five Years of Age Rosario Rojas (Chile)
3056
Prevalence Allergic Diseases and Allergic Sensitization Among Urban Office Workers As Compared with a Forest Service Workers | Woo Kyung KIM (South Korea)
3057
Photoaging Attenuates Skin Test Response to Histamine More Than Natural Aging David Fitzhugh (US)
Poster Session 23: Occupational Allergies
Poster Hall (Cancún Center)
3058
Prevalence of Latex Sensitization Between Medicine and Dentistry Students From Nuevo Leon University | Arya González (Mexico)
3059
Profile of Latex Sensitization in Children with Myelomeningocele of São Paulo, Brazil | Adriano Sa (Brazil)
3060
Specific IgE to Recombinant Allergens of Latex and Foods in Patients with Spina Bifida | Laila Sabino Garro (Brazil)
3061
Association Between Clinical History and Specific IgE Recombinants Latex Allergens | Laila Sabino Garro (Brazil)
3062
Contact Reactions to Latex, Its Additives and Irritant Threshold In Healthcare Practitioners | Razvigor Darlenski (Bulgaria)
3063
Occupational Flaxseed Allergy (Conjunctivitis): A Case Report Arnaldo Capriles- Hulett (Venezuela)
3064
Occupational asthma: description of a new allergen | Lizette del Carmen Miguel Polo (Spain)
Poster Session 24: Contact Dermatitis
Poster Hall (Cancún Center)
3065
Patch Testing Results In Contact Dermatitis From the Allergist's Perspective | Marcella Aquino (US)
3066
Contact Allergy to Medicaments in Consecutively Patch-Tested Patients in Uruguay | Valeria Pomies (Uruguay)
3067
Evaluation of Allergen Sensitivity In Patients with Contact Dermatitis In Antalya | Arzu Didem Yalcin (Turkey)
3068
Better Protection From Eczema Among Turkish Migrants' Children Carries Over From Preschool Age to Adolescence | Christoph Grüber (Germany)
Poster Session 25: Atopic Dermatitis
Poster Hall (Cancún Center)
3069
Early Clinical Differential Diagnosis Between Infant Atopic Dermatitis and Seborrheic Eczema | Rubens Marcelo Souza Leite (Brazil)
3070
Sensitization to Contactants In Patients with Atopic Dermatitis | Fausto Matsumoto (Brazil)
3071
Sensitization to Aeroallergens and Risk of Respiratory Allergy in Atopic Dermatitis Children | Natalya Migacheva (Russia)
3072
Nutritional Evaluation of Children with Atopic Dermatitis | Xiomara Lopez Campos (Cuba)
3073
Quality of Life In Pediatric Patients with Atopic Dermatitis | Xiomara Lopez Campos (Cuba)
3074
Epidemiology of Atopic Dermatitis In the Allergy Service of A Third Level Medical Center | Luis Rafael Sanchez-Gallardo (Mexico)
3075
Epidemiology of Atopic Dermatitis Cases In the Allergy Service of A Third Level Medical Center | Luis Rafael Sanchez-Gallardo (Mexico)
3075
Gene-Environment Interactions on the Development of Atopic Dermatitis in Preschool Children: Mold Is the Main Environmental Factor Soo-Jong Hong (South Korea)
3076
FcRg-Mediated Immune Responses Modulate the Exacerbation of Clinical Symptoms in Atopic Dermatitis of NC/Tnd Mice | Kumiko Oida (Japan)
Poster Session 26: Drug Allergy 2
Poster Hall (Cancún Center)
3077
Hypersensitivity Syndrome Associated with Phenytoin Sodium | Elizabeth Mendieta (Mexico)
3078
Drug Hypersensitivity Reactions In Hospitalized Patients: What Is the Hole of the Allergist? | Luciana Kase Tanno (Brazil)
3079
Allergic Reactions to Local Anesthetics: Detection by Skin Tests and Subcutaneous Provocation. Analysis of 160 Cases José Luiz Rios (Brazil)
3080
Protamine Allergy | Christine Hafner (Austria)
3081
Description of Drug Allergy Study Conducted In A Teaching Hospital Between October 2007 and March 2011 | Consuelo Fernanda Rodríguez Martínez (Chile)
3082
Lung Toxicity Induced by Novel Antineoplastic Therapies In Cancer Patients | Kostas N. Syrigos (Greece)
3083
Redness of Skin: SSSS in a 10 Month Old Healthy Baby | Agnes Nemeth (Hungary)
3084
Desensitization Protocol to Methotrexate | Jonathan Maya (Mexico)
3085
Clinical Features of Dress Syndrome In 42 Patients | Mi-Ran Park (South Korea)
3086
Risk Factors Associated to Mortality In Mexican Children with Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis | Luis Octavio Hernandez-Mondragon (Mexico)
Poster Session 27: Aspirin-Exacerbated Respiratory Disease
Poster Hall (Cancún Center)
3087
Successful Treatment of Severe Nonallergic Asthma by Omalizumab. An Observation | Karl-Christian Bergmann (Germany)
3088
Relationship Between Aeroallergen Sensitization and Asthma Severity in Patients with Aspirin-Exacerbated Respiratory Disease | Chihiro Mitsui (Japan)
3089
Persistence of Nasal and Bronchial Symptoms in Patients with Samter's Syndrome with Treatment Medical and Surgical in a 2 Year Period | Hugo Alberto Azuara Trujillo (Mexico)
3090
Clinics and Laboratory Characteristics of Asthmatic Patients with Aspirin Exacerbated Respiratory Disease (AERD) Pedro Giavina-Bianchi (Brazil)
3091
Association Analysis of Member RAS Oncogene Family Gene Polymorphisms with Aspirin Intolerance in Asthmatic Patients Tae-Hoon Kim (South Korea)
3092
Nasal Nitric Oxide Levels After Lysine Aspirin Nasal Challenge In Subjects with Aspirin Induced Asthma | Damian Tworek (Poland)
3093
IL1B but Not IL8 Polymorphisms Are Increased in Aspirin Exacerbated Respiratory Disease Patients Versus Aspirin Tolerant Asthmatics | Fernando Gandhi Pavon Romero (Mexico)
3094
Fatty Acid Binding Protein 1 Is Related with Development of Aspirin-Exacerbated Respiratory Disease | Tae-Hoon Kim (South Korea)
Poster Session 28: Immunotherapy Training
Poster Hall (Cancún Center)
3095
Immunotherapy (IT) Training in Canada: Perspectives of Fellows-in-Training on the First Immunotherapy Training Manual | Teresa Pun (Canada)
3096
Immunotherapy (IT) Training in Canada: Current Experience of Fellows-in-Training | Teresa Pun (Canada)
Poster Session 29: Food Allergy Case Reports
Poster Hall (Cancún Center)
3097
Lentil Allergy: First Report From Venezuela Arnaldo Capriles Hulett (Venezuela)
3098
Cow's Milk Allergy and Persistent Changes in a Multiple Food Allergy, a Case Report Carla Bastías (Chile)
3099
A Rare Case of Food-Induced Anaphylaxis to Pink Peppercorns | John Kim (US)
3100
Multiple Manifestations of Food Allergy in a Patient with a Change of Eating Habits Carla Bastías (Chile)
3101
Wheat-Dependent Exercise-Induced Anaphylaxis Occurred in OAS Patient After Using Soap Containing Hydrolyzed Wheat Proteins: Effect of Soap on Keratinocyte Inflammasome | Aya Tanaka (Japan)
Poster Session 30: Food Allergy: Diagnosis and Treatment
Poster Hall (Cancún Center)
3102
Possible Prenatal Sensitization: "the Case of the Hidden Cake" | José Antonio Ortega Martell (Mexico)
3103
The Evaluation of Allergen Sensitivity In Food Allergy Patients In Antalya, Turkey | Arzu Didem Yalcin (Turkey)
3104
Clinical Correlation of Prick and Prick-to- Prick Skin Tests to Food in a Group of Children with Allergy Symptoms Armando Partida-Gaytan (Mexico)
3105
Comparison Skin Prick Test Using Commercial and Native Extracts of Allergens in Diagnosis of Food Allergy | Zbigniew Bartuzi (Poland)
3106
Natural History of Food Allergy in Childhood -3 Years' Follow up of Pediatric Food Allergy Patients- | Miho Hasegawa (Japan)
3107
Comparative Analysis of Patients with Birch Pollinosis and Patients with Associated Plant Food Allergy | Zbigniew Bartuzi (Poland)
3108
Frequency and Characterization of Oral Allergy Syndrome in Mexican Adults with Nasal Pollinosis | Martín Bedolla Barajas (Mexico)
3109
Edirne Primary School Teacher Knowledge of Food Allergies and Emergency Treatment Facilities in Schools | Mehtap Yazicioglu (Turkey)
Poster Session 31: Eosinophilic Diseases
Poster Hall (Cancún Center)
3110
International Survey On Evaluation and Management of Eosinophilic Esophagitis | Gisoo Ghaffari (US)
3111
Allergen Specific Immunotherapy As a Treatment for Eosinophilic Esophagitis | Juan Esteban Perez (US)
3112
Eosinophilic Esophagitis and Eosinophil Cationic Proteins As Marker of Disease During the Follow-up | Erminia Ridolo (Italy)
Poster Session 32: Immunodeficiency
Poster Hall (Cancún Center)
3113
Severe Autoimmunity with Polyarticular Joint Disease Requiring Anti-TNF Therapy and T+B-NK+ Immunodeficiency In a Family with Small Stature and Intermediate Radiation Sensitivity Jun Lu (US)
3114
Autoimmunity in Patients with Allergy and Immunodeficiency: As Result of the Immune Chronic Inflammation | Julia Mendez-Inocencio (Mexico)
3115
HPV, HSV2, HIV and Chlamydia Trachomatis Infections As a Potential Accompanying Factor for Immunodeficiency and Development of Allergic Processes. Final Results | Maria Gołębiowska-Wawrzyniak (Poland)
3116
A 3 Years-Old Child with Specific Antibody Deficiency and Allergic Rhinitis. Case Report | Maria Edith Gonzalez Serrano (Mexico)
3117
Silvery-Gray Hair Patient with Neurologic Deterioration | Luisa Gamez (Mexico)
3118
Differences IN Humoral and Cellular Immunity IN Young and OLD Individuals | Arzu Didem Yalcin (Turkey)
3119
Analysis of the Immune Status in the Acute Phase of Viral Respiratory Infections in Children | Olga Bede (Hungary)
3120
Immunomodulatory Effects of Human Bone Marrow-Derived Mesenchymal Stem Cells | Maryam Ayatollahi (Iran)
3121
Immunosuppressed Murine Model for Studies in Allergy: Evaluation of Immunosuppression Induced by Cyclophosphamide, Dexamethasone and Cyclosporin in Balb-C Mice | Adriano Pereira (Brazil)
Poster Session 33: Primary Immunodeficiency
Poster Hall (Cancún Center)
3122
Intravenous Immunoglobulin in Leukocyte Adhesion Deficiency | Said Arablin Oropeza (Mexico)
3123
Descriptive Analysis of the Immunological Behavior of Patients with Ataxia Telangiectasia Attended in the National Institute of Pediatrics in the Past 30 Years | Beatriz Adriana Llamas (Mexico)
3124
Alteration of Humoral and Cellular Immunity in Patients with Ataxia-Telangiectasia At Reference Center in Sao Paulo/Brazil | Lorena Ornellas (Brazil)
3125
Clinical Features of Patients with Ataxia-Telangiectasia At Reference Center in Sao Paulo/Brazil | Josemar Matos (Brazil)
3126
Attentiveness to Primary Immunodeficiency: Survey of Pediatricians in United Arab Emirates | Suleiman Al-Hammadi (United Arab Emirates)
3127
The Diagnosis of Primary Immune Deficiency in Adults Should Not Be Missed: A Delayed Diagnosis Can Be Devastating Abdullah Baysan (Turkey)
3128
Global Prevalence and Types of Autoimmune Diseases Found in Children with Primary Immunodeficiencies; a Single-Center Experience | María Guadalupe Ramírez Vázquez (Mexico)
3129
Malignancies associated to Primary Immunodeficiencies. A 40 year review | Corin España (Mexico)
3130
An Earlier, Moore Severe Presentation of G6PC3 Deficiency in a Male Infant From Mexico | Alonso Cruz (Mexico)
3131
Immunoglobulin A deficiency, HPV and Oral Cancer | Jorge Alvarez (Argentina)
Poster Session 34: X-linked and Common Variable Immunodeficiency
Poster Hall (Cancún Center)
3132
Long Term Follow-up of Patients with Common Variable Immunodeficiency (CVID) in Rio De Janeiro, Brazil: Clinical Phenotypes and Prognosis | Amanda Seba (Brazil)
3133
Quality of Life in Patients with Common Variable Immunodeficiency in the Department of Allergy and Clinical Immunology - Centro Medico Nacional Siglo XXI | Freya Helena Campos Romero (Mexico)
3134
"PREVALENCE of COMMON Variable Immunodeficiency In ADULT PATIENTS” Specialty HOSPITAL – Centro Medico Nacional Siglo XXI - MSS - Mexico CITY | Nelva Guillén (Mexico)
3135
Infections in 14 Patients with Common Variable Immunodeficiency, Retrospective Study | Elizabeth Mendieta (Mexico)
3136
Autoimmune Thrombocytopenic Purpura Associated with Common Variable Immunodeficiency | Elizabeth Mendieta (Mexico)
3137
CVID: A Common but Still Underdiagnosed Disease | Claudia Gallego (Mexico)
3138
Infections in Patients Diagnosed with Common Variable Immunodeficiency Arzu Didem Yalcin (Turkey)
3139
Phenotypic and Functional Analysis of B Cells In Patients with Common Variable Immunodeficiency Dolores Mogica Martínez (Mexico)
3140
X-Linked Agammaglobulinemia: Report of 4 Cases of Mexican Patients At Civil Hospital of Guadalajara Dr Juan I. Menchaca | Maria Enriqueta Nuñez-Nuñez (Mexico)
3141
Congenital Agamaglobulinemia | Cinthia Perez Ortiz (Paraguay)
3142
Case Report: Hypogammaglobulinemia Induced by Oxcarbazepine Rosario Rojas (Chile)
3143
X- Linked Agammaglobulinemia and Moebius Syndrome, First Case Reported | Margarita Ortega-Cisneros (Mexico)
Poster Session 35: HIV-Related Problems
Poster Hall (Cancún Center)
3144
Peculiarities of HIV-Specific Immune Response in Discordant Couples | Evgenia Zhukova (Russia)
3145
Detection of Dengue Virus in HIV-1-Infected Patients During the Epidemic in 2009 in Colima, Mexico | Uriel A. López-Lemus (Mexico)
3146
HPV, HSV2, HIV and Chlamydia Trachomatis Infections As a Potential Accompanying Factor for Immunodeficiency and Development of Allergic Processes Final Results | Katarzyna Markiewicz (Poland)

12:45 - 14:15

Poster Symposium 3: Allergic Rhinitis
Bacalar (Cancún Center)
 Chairpersons: Glenis Scadding (United Kingdom) and Michael A. Kaliner (US)
12:45 - 13:30
Poster Viewing
13:30 - 00:00
3148: Allergen Sensitization In Children with Allergic Rhinitis and Asthma In Guatemala | Ann Michelle Rigalt (Guatemala)
13:30 - 00:00
3149: The Impact of Breast-Feeding Duration and Mode of Delivery on Allergic Rhinitis in Korean Children: Cohort of Allergic Rhinitis in Korea (COAR-Korea) Study | Doo Hee Han (South Korea)
13:30 - 00:00
3150: The Efficacy of a Nasal Corticosteroid Ciclesonide for the Treatment of Serous Otitis Media In Atopic Children | Safa Nsouli (US)
13:30 - 00:00
3151: A Study Evaluating the Efficacy and Safety of Ciclesonide Hydrofluoroalkane Nasal Aerosol In the Relief of Nasal Symptoms of Seasonal Allergic Rhinitis Shailesh Desai (US)
13:30 - 00:00
3152: Combination of a Nasal Antihistamine Olopatadine and a Leukotriene Receptor Antagonist Montelukast Sodium for the Treatment of Seasonal Allergic Patients Not Currently Controlled On Monotherapy Intranasal Antihistamine or a Leukotriene Receptor Antagonist | Safa Nsouli (US)
13:30 - 00:00
3153: Desloratadine Is Safe and Well Tolerated in Adults ³55 Years Old Gokul Gopalan (US)
13:30 - 00:00
3154: Augmentation of CXCL10 Expression in Nasal Fibroblasts Derived From Patients with Recalcitrant Chronic Rhinosinusitis Associated with Bronchial Asthma | Mamoru Yoshikawa (Japan)
13:30 - 00:00
3155: Correlation Between Cu/Zn-SOD and Macrophages or MUC5AC in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps | Noritsgu Ono (Japan)
13:30 - 00:00
3156: Relationship Between Allergic Rhinitis and Dental-Facial Abnormalities | Miguel Alejandro Medina (Mexico)
Oral Abstract Session 12: Food & Drug Allergy: Late-Breakers
Gran Cancún 1 (Cancún Center)
 Chairpersons: Daniel Yerly (Switzerland) and Emilia María Hidalgo Castro
12:45 - 13:00
3157: DELAYED- TYPE HYPERSENSITIVITY TO AMINOPENICILLINS: “HANDS DESQUAMATION SYNDROME” | Lizette del Carmen Miguel Polo (Spain)
13:00 - 13:15
3158: Influence of Transglutaminase and the Reducing Agent Glutathione in the Gastric Digestion and Immunogenicity of Beta-Lactoglobulin Mariana Battaglin Villas-Boas (Brazil)
13:15 - 13:30
3159: Immediate and no immediate reactions induced by iodinated contrast medium nonionic among hospitalized patients: incidence and severity | Martín Bedolla-Barajas (Mexico)
13:30 - 13:45
3160: Severe Cutaneus Drug Reactions: Description of a Serie Cases | Fátima Fernandes (Brazil)
14:00 - 14:15
3162: Frequency of Sensitization for Food and Aero-Allergens in Patients Recieved in a Venezuelan Laboratory During 2010-2011 Period Cristina Najm (Venezuela)
Oral Abstract Session 13: Allergen Structure 2
Gran Cancún 2 (Cancún Center)
 Chairpersons: Heimo Breiteneder (Austria) and Barbara Cases (Spain)
12:45 - 13:00
3163: Proteomic and Immunological Characterization of Ragweed Allergens | Steffen Augustin (Germany)
13:00 - 13:15
3164: Proteomic Analysis of Major and Minor Allergens From Isolated Pollen Cytoplasmic Granules | Oussama Abou Chakra (France)
13:15 - 13:30
3165: Cross-Reactivity Between Olive Pollen and 3 Species of Grasses in Madrid, Spain | Enrique Fernandez-Caldas (Spain)
13:30 - 13:45
3166: Molecular Properties and Immunological Reactivity of Arabidopsis EXPB1, a Non-Allergenic Homologue of Grass Group 1 Allergens | Mohan Singh (Australia)
13:45 - 14:00
3167: Protein-protein interactions determine IgE reactivity to polygalacturonase from Cupressus sempervirens pollen | Youcef Shahali (France)
14:00 - 14:15
3168: Grafting of Bet v 1 Epitopes Onto Its Homologue Api g 1 Reveals Patient-Specific IgE Recognition Profiles | Barbara Gepp (Austria)
Oral Abstract Session 14: Anaphylaxis
Gran Cancún 3 (Cancún Center)
 Chairpersons: F. Estelle R. Simons (Canada) and Felicidad Cua-Lim (Philippines)
12:45 - 13:00
3169: Immunologic Evaluation of the Patients with Ranitidine Anaphylaxis | Hyun-Jung Jin (South Korea)
13:00 - 13:15
3170: Body Mass Index (BMI) and Immediate (“Stat”) Dose of Epinephrine IM (epi IM) Needed to Treat Subcutaneous Allergen Immunotherapy (SCIT) Systemic Reactions (SRs) | Michel Alkhalil (US)
13:15 - 13:30
3171: Muscle Relaxant Induced Allergic Reactions | Gyu-Young Hur (South Korea)
13:30 - 13:45
3172: Features of 51 Patients with Perioperative Anaphylaxis History | Laila Sabino Garro (Brazil)
13:45 - 14:00
3173: Drug Induced Anaphylaxis In A University Hospital In Sao Paulo, Brazil | Marcelo Vivolo Aun (Brazil)
14:00 - 14:15
3174: Analysis of Anaphylactic Reactions to Biological Agents Reported to the Italian Pharmacovigilance Database Giovanna Zanoni (Italy)
Oral Abstract Session 15: Global Asthma Epidemiology
Gran Cancún 4 (Cancún Center)
 Chairpersons: Jing Li (China) and Gailen Marshall (US)
12:45 - 13:00
3175: Recurrent Wheezing In Infancy: Epidemiological Changes Between EISL Phase I and III | Herberto Jose Chong Neto (Brazil)
13:00 - 13:15
3176: Asthma Admission Rates in Germany: An Analysis of the Nationwide DRG-Statistic of the Year 2009 | Maria Weyermann (Germany)
13:15 - 13:30
3177: Prevalence and Classification of Asthma In Freshmen Students of A Guatemalan University and Its Relationship with Aeroallegens Sensitization | Juan Pablo Maselli (Guatemala)
13:30 - 13:45
3178: Asthma Mortality in Brazil (1998-2006) Adelmir Souza-Machado (Brazil)
13:45 - 14:00
3179: Dose Response Relationship Between Ascaris Sensitisation and Atopy and Bronchial Hyper-Responsiveness but Not Allergic Diseases in Black South Africans | Michael Levin (South Africa)
14:00 - 14:15
3180: Association of Matrix Metalloproteinase-7 and -12 Genes Polymorphisms with Asthma: A Case-Control Study of MMP-7 and -12 In a Japanese Population | Fumiya Yamaide (Japan)
Oral Abstract Session 16: Hereditary Angioedema
Gran Cancún 5 (Cancún Center)
 Chairpersons: Michael Frank (US) and Bruce Zuraw (US)
12:45 - 13:00
3181: Hereditary Angioedema and Normal C1-Inhibitor (HAE Type III): A Novel Mutation In the Coagulation Factor 12 Gene | Konrad Bork (Germany)
13:00 - 13:15
3182: Immuno-Safety of Recombinant Human C1 Inhibitor in Patients with Hereditary Angioedema: An Integrated Analysis Anurag Relan (Netherlands)
13:15 - 13:30
3183: Clinical Efficacy of Recombinant Human C1 Inhibitor in Patients with Acute Hereditary Angioedema Attacks Marc Riedl (US)
13:30 - 13:45
3184: Open-Label Use of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INH-nf) for the Prophylaxis of Hereditary Angioedema (HAE) Attacks William Lumry (US)
13:45 - 14:00
3185: The Efficacy and Safety of Human Plasma-Derived C1-Inhibitor Concentrate Administered for the Treatment of Attacks in Pediatric Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency | Henriette Farkas (Hungary)
14:00 - 14:15
3186: Treatment of Idiopathic Nonhistaminergic Angiodema with Icatibant | Ramon Lleonart (Spain)
Oral Abstract Session 17: Immunomodulators
Cozumel 2 (Cancún Center)
 Chairpersons: Jorge Kalil (Brazil) and Anthony Frew (United Kingdom)
12:45 - 13:00
3187: Modulation of Human Basophilic Responses by a Fibroleukin-Allergen Fusion Protein | Maaike Dooper (Norway)
13:00 - 13:15
3188: Immunogenicity and Safety Aspects of Adeno-Associated Virus–Like Particles (AAVLPs) As Carriers for B-Cell Vaccines | Erika Jensen-Jarolim (Austria)
13:15 - 13:30
3189: M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy Cornelia Schultz (Austria)
13:30 - 13:45
3190: Neisseria Meningitidis Derived Proteoliposome As An Adjuvant for Allergen Vaccines | Wendy Ramírez González (Cuba)
13:45 - 14:00
3191: Immunomodulatory Effects of Manumycin-Type Antibiotics On Human Macrophages | Ilja Striz (Czech Republic)
Oral Abstract Session 18: Inhaled Corticosteroids for Asthma
Isla Mujeres (Cancún Center)
 Chairpersons: Diana Deleanu (Romania) and Stanley Szefler (US)
12:45 - 13:00
3192: A Post-Hoc Analysis of Asthma Control and Lung Function Following Treatment with Ciclesonide 80 µg HFA-MDI Twice Daily In Subjects with Mild-to-Moderate Persistent Asthma Previously Receiving Low Dose Fluticasone Propionate/Salmeterol | Eli Meltzer (US)
13:00 - 13:15
3193: The Particle Size of Mometasone Furoate 100 Mcg and 200 Mcg Dry Powder Formulations | Robert Berger (US)
13:15 - 13:30
3194: Clinical Efficacy of Once-Daily Mometasone Furoate in Children with Persistent Asthma Switched From Treatment with Fluticasone Propionate Ariel Teper (US)
13:30 - 13:45
3195: Inhaled Mometasone Furoate Improved Efficacy in Pediatric Asthma Patients Regardless of Previous Inhaled Corticosteroid Therapy: Pooled Data From the Ariel Teper (US)
13:45 - 14:00
3196: Comparison of the Use Ciclesonide Versus Fluticasone for the Treatment of Asthma in Children | Said Arablin Oropeza (Mexico)
14:00 - 14:15
3197: Mometasone Furoate Vs Fluticasone Propionate in Mild Persistent Asthma: Retrospective Analysis of Asthma Control and Adherence Felicia Allen-Ramey (US)
Oral Abstract Session 19: Mechanisms of Allergic Inflammation
Tulum (Cancún Center)
 Chairpersons: Mubeccel Akdis (Switzerland) and Hirohisa Saito (Japan)
13:00 - 13:15
3199: Type I and III Interferon Are Attenuated in a Human Invitro Model of Alternatively Activated Macrophages | Ashraf EL Fiky (US)
13:15 - 13:30
3200: A Highly Sensitive and Specific Universal Mirna Profiling Method | Jia-Wang Wang (US)
13:30 - 13:45
3201: Caspase-4 Plays a Role in the Activation of the Cryopyrin/NLRP3 Inflammasome | Ruan Cox Jr. (US)
13:45 - 14:00
3202: Genome-Wide Association Studies of Asthma Indicate Opposite Immunopathogenesis Direction From Autoimmune Diseases | Xingnan Li (US)
14:00 - 14:15
3203: Allergy Is An Epithelial Barrier Disease | Risto Renkonen (Finland)
Oral Abstract Session 20: Patho-Biology of Nasal Polyps
Xcaret (Cancún Center)
 Chairpersons: Robert Naclerio (US) and Mark Glaum (US)
12:45 - 13:00
3204: Mutiplex Analyses of Cytokine and Chemokine Release From the Cultured Fibroblast of Nasal Polyp: The Effect of IL-17A | Katsuhisa Ikeda (Japan)
13:00 - 13:15
3205: Expression of Chemokine Receptors CCR1, CCR3, CCR4, CCR5, CCR8 and CXCR3 in Human Nasal Polyps (NP); Cmparison with NP From Allergic Patients with Aspirin Intolerance | Petra Fundova (Czech Republic)
13:15 - 13:30
3206: Characterization of Two Epithelial Cell Air-Liquid Interface (ALI) Culture Models for Human Healthy Nasal Mucosa and Nasal Polyps | Fco. de Borja Callejas (Spain)
13:30 - 13:45
3207: Corticosteroid Treatment Reduces Tissue Eosinophilia and the Expression of Matrix Metalloproteinases (MMP-1, MMP-2, MMP-7, MMP-9) and Their Tissue Inhibitor (TIMP-1) in Nasal Polyps | Fco. de Borja Callejas (Spain)
13:45 - 14:00
3208: Expression and Localization of CysLT2 Receptor In Human Nasal Mucosa | Shirasaki Hideaki (Japan)
14:00 - 14:15
3209: Increased Expression and Role of Thymic Stromal Lymphopoietin In Nasal Polyposis | Satoko Kimura (Japan)
Oral Abstract Session 21: Respiratory Infections
Costa Maya 1 (Cancún Center)
 Chairpersons: Robert C. Strunk and Hyun Hee Kim (South Korea)
12:45 - 13:00
3210: Inhibition of AKT Kinase Activity Decreases Replication of Human Respiratory Syncytial Virus Michael Teng (US)
13:00 - 13:15
3211: Abnormal Immune Response Against Respiratory Pathogens In Olympic Athletes | Marcin Kurowski (Poland)
13:15 - 13:30
3212: The Immune Response Against Respiratory Pathogens in Patients with Chronic Rhinosinusitis/Nasal Polyps and Asthma with or without Sensitivity to Aspirin | Agnieszka Olszewska-Ziąber (Poland)
13:30 - 13:45
3213: Immunologic and Clinical Characteristics of Pediatric Population with Human Influenza Virus H1N1 infection in Federal Hospital of Mexico | Jaime Mellado-Abrego (Mexico)
13:45 - 14:00
3214: Evaluation of Various Forms of Sinusitis Using Bone SPECT | Sergul Ulus (Turkey)
14:00 - 14:15
3215: Rhinitis: WHERE IS the Biofilm? | Matteo Gelardi (Italy)
Oral Abstract Session 22: Rhinitis Treatment 1
Costa Maya 2 (Cancún Center)
 Chairpersons: Michael S. Blaiss (US) and Teet Pullerits (Sweden)
12:45 - 13:00
3216: A 6-Week Study of the Efficacy and Safety of Ciclesonide Hydrofluoroalkane Nasal Aerosol In the Relief of Nasal Symptoms of Perennial Allergic Rhinitis John Karafilidis (US)
13:00 - 13:15
3217: 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine | Nils Achilles (Germany)
13:15 - 13:30
3218: Levels of VCAM and ICAM In Patients with Allergic Rhino-Conjunctivitis and H1 Antihistamines | Ioana Adriana Bujor (Romania)
13:30 - 13:45
3219: Once Daily Intranasal Fluticasone Furoate Decreases Daytime Sleepiness and Improves Cognitive Performance in Symptomatic Seasonal Allergic Rhinitis | Alejandro Diaz (US)
13:45 - 14:00
3220: International Survey on the Management of Allergic Rhinitis by Physicians and Patients (ISMAR). Physicians' View | H A Badellino (Argentina)
14:00 - 14:15
3221: International Survey on the Management of Allergic Rhinitis by Physicians and Patients (ISMAR): The Patients' View | Alvaro Teijeiro (Argentina)
Oral Abstract Session 23: Sublingual Immunotherapy 2
Auditorium (Cancún Center)
 Chairpersons: Giorgio Walter Canonica (Italy) and Linda Cox (US)
12:45 - 13:00
3222: Therapeutic Effect and Safety of the Sublingual Immunotherapy with Tropical House Dust Mite Allergen Vaccines in Asthmatic Cuban Adult Patiens | Raúl Lázaro Castro Almarales (Cuba)
13:00 - 13:15
3223: Candidate for Response Monitoring or Prognostic Biomarkers In Two-Year Sublingual Immunotherapy for Japanese Cedar Pollinosis | Takashi Fujimura (Japan)
13:15 - 13:30
3224: Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in US Adults with Grass-Pollen Allergic Rhinoconjunctivitis | Linda Cox (US)
13:30 - 13:45
3225: Establishing the Effectiveness, Cost-Effectiveness and Safety of Oral and Sublingual Immunotherapy for Food Allergy: A Systematic Review and Meta-Analysis of Intervention Studies | Ulugbek Nurmatov (United Kingdom)
13:45 - 14:00
3226: Safety of Timothy Grass Allergy Immunotherapy Tablet In North American Adults and Children | Peter Creticos (US)
14:00 - 14:15
3227: Safety and Tolerability of Timothy Grass Allergy Immunotherapy Tablet In Adults and Children with Allergic Rhinoconjunctivitis: Post Hoc Analysis of 7 Clinical Trials | Hendrik Nolte (US)

Wednesday, 7 December 2011

Sunday | Monday | Tuesday | Wednesday | top

12:15 - 14:15

Poster Session 36: Epidemiology of Allergic Rhinitis
Poster Hall (Cancún Center)
4000
Treatment of Nasal Allergies: Results From the Allergies Surveys in America, Asia Pacific, Latin America, and Middle East | Michael S. Blaiss (US)
4001
Comorbid Allergy-Related Respiratory Conditions Among Children and Adults Diagnosed with Allergic Rhinitis: Findings From Research Jointly Funded by the AAAAI and ACAAI | Cheryl Hankin (US)
4002
Survey of Rhinitis Phenotypes | Sergio Bonini (Italy)
4003
Prevalence and Risk Factors Associated to Symptoms of Rhinoconjunctivitis In Mexican School Children. A Multicenter Study | Mayra Alondra Livano Prez (Mexico)
4004
Oral Allergy Syndrome and United Airways Disease: Is There a Functional Connection? | Carlo Lombardi (Italy)
4005
Epidemiological and Clinical Characteristics of Allergic Conjunctivitis Patients in a Reference Center of Mexico City | Atzin Robles-Contreras (Mexico)
4006
The Classification of Allergic Rhinitis and ITS Cytological Correlate | Matteo Gelardi (Italy)
4007
Incidence of Allergic Diseases on Children Under 5 Years in Juarez Hospital Mexico | María Isabel Rojo Gutiérrez (Mexico)
Poster Session 37: Diagnostic Test for Allergic Rhinitis
Poster Hall (Cancún Center)
4008
Comparison of Skin and Conjunctival Reactivity to Aeroallergens Nelson Rosario (Brazil)
4009
Correlation Between Skin Prick Test and MAST Results In Patients with Chronic Rhinitis Jin Hee Cho (South Korea)
4010
Cutaneous Response to Patch Tests with Dermatophagoides Farinae and Dermatophagoides Pteronyssinus in Patients with Chronic Rhinitis | Diego Garcia-Calderin (Mexico)
4011
Skin Prick Test Reactivity Compared to Serum Specific IgE by ISAC in Patients with Rhinitis | Laura Araujo (Brazil)
4012
Alteration of Smell In Patients with Persistent Allergic Rhinitis Alvaro Teijeiro (Argentina)
4013
Effectiveness of an Educational Intensive Course on A/I Clinical and Diagnostic Procedures Morna Dorsey (US)
Poster Session 38: Allergic Rhinitis
Poster Hall (Cancún Center)
4014
PCR Analysis of Microorganisms in Chronic Rhinosinusitis with Nasal Polyps | Mikio Hirotsu (Japan)
4015
Incidence of Allergy to Artemisia Vulgaris and Salsola Kali In Sabzevar City | Zahra Matloobi (Iran)
4016
The Prevalence of Allergic Rhinitis in Adolescent in the “La Paz-Bolivia” City. (3600 m.s.n.m.) | Abel Marcelo Moncada Alcon (Bolivia)
4017
Pattern of Positive Sensitization in Patient with Asthma and Rhinitis to 3600 Msnm (La Paz-Bolivia) | Abel Marcelo Moncada Alcon (Bolivia)
4018
Epidemiology of Allergic Rhinitis Cases In the Allergy Service of A Third Level Medical Center. Six Year Experience | Luis Rafael Sanchez-Gallardo (Mexico)
4019
The Evaluation of Allergen Sensitivity In Allergic Rhinoconjunctivitis and Allergic Asthma Patients In Antalya, Turkey | Arzu Didem Yalcin (Turkey)
4020
Allergic Disease Severity and Relations | Filipa Viveiros (Portugal)
4021
Frequency of Patients with Clinical Manifestations of Allergic Rhinitis without Evidence of Systemic Atopy and Specific IgE Sensitization | Norma de Paula Motta Rubini (Brazil)
4022
H1 Antihistamines INFLUENCE On PRO-INFLAMMATORY Cytokines LEVEL In PATIENTS with Allergic Rhinitis | Ioana Corina Bocsan (Romania)
4023
International Survey On the Management of Allergic Rhinitis by Physicians and Patients (ISMAR) | R M Gomez (Argentina)
4024
Effectiveness of Sinus Surgery for Lower Airway Disease | Ryoji Kagoya (Japan)
4025
Berberine Inhibits Myofibroblast Differentiation in Nasal Polyp-Deroved Fibroblast Via p-38 Pathway | Heung-man Lee (South Korea)
4026
Results of the Rhinoconjunctivitis Related Quality of Life Questionnaire Administered to Subjects with Seasonal Allergic Rhinitis Following Treatment with Ciclesonide Hydrofluoralkane Nasal Aerosol Shailesh Desai (US)
4027
Mold Sensitization in Chronic Rhinosinusitis Patients | Radoslaw Gawlik (Poland)
4028
“Nasal Cytology Is Important In the Classification of Patients with Allergic and Non-Allergic Rhinitis.” | Olavo Mion (Brazil)
4029
The Examination of the Association Between the Chronic Rhinosinusitis and the Inflammation of the Lower Respiratory Airway by Using the Exhaled Nitric Oxide(NO) and the Respiratory Function Test | Hiroyoshi Yoshinami (Japan)
4030
Peak Inspiratory Flow Rate Is More Sensitive Than Acoustic Rhinometry or Rhinomanometry In Detecting Nasal Obstruction Using the Allergen Challenge Chamber | Tetsuya Terada (Japan)
4031
Nasal Poliposis and Allergic Disease. Dr. Salvador Allende Hospital | Ada Castillo Méndez (Cuba)
4033
Use of the CT Navigation In the Rhinology and Head Surgery | Petra Fundova (Czech Republic)
4034
Rupatadine oral solution is efficacious and safe in children ( aged 6-11 years) with persistent allergic rhinitis | Paul Potter (South Africa)
4035
Assessment of the Quality of Methodological Rigour and Reporting of Clinical Practice Guidelines for the Management of Allergic Rhinitis – QUGAR study | Agnieszka Padjas (Poland)
4036
Health-Related Quality of Life and Prognostic Value of Acoustic Rhinometry in Patients with Perennial Allergic Rhinitis Treated with Fix Combination of Montelukast plus Desloratadine | Cemal Cingi (Turkey)
Poster Session 39: Conjunctivitis
Poster Hall (Cancún Center)
4037
Tear IL-4 Is Decreased in Allergic Conjunctivitis Patients with Negative Skin Test After Dialyzable Leukocyte Extracts Treatment | Gustavo Aguilar-Velazquez (Mexico)
4038
Histochemical Study of Allergic Inflammation in Conjunctiva From Ovalbumin Sensitized Rabbits After Ocular or Nasal Challenge | Rocio Batle (Argentina)
4039
Prevalence of Allergic Conjunctivitis in Childhood Herberto Jose Chong Neto (Brazil)
4040
Effects of Omalizumab in Children with Atopic Keratocojunctivitis: A New Treatment for Severe Ocular Allergies? – Report of Two Cases | Fábio Kuschnir (Brazil)
4041
Allergic Conjunctivitis, Allergic Comorbitidies and the Most Common Allergens Identified In A Group of Mexican Patients | Guillermina Cortés-Morales (Mexico)
4042
Giant Papillary Conjuntivitis without Associated Triggers. Report of Two Cases | Aida Gonzalez-Carsolio (Mexico)
4043
Contact Allergy Due to Ophthalmic Drugs in Uruguay | Valeria Pomies (Uruguay)
4044
Increased Frequency of γδ T Cells in Patients with Allergic Conjunctivitis | Miguel E Alonso-Sánchez (Mexico)
4045
Zero Itch in Eyes Treated with Olopatadine Hydrochloride Ophthalmic Solution, 0.2% in Bilateral Conjunctival Allergen Challenge Studies | Michael S. Blaiss (US)
Poster Session 40: Mastocytosis
Poster Hall (Cancún Center)
4046
Mastocytosis and IgE-Dependent Sensitization: Report of 2 Cases Carla Bastías (Chile)
4047
Mastocytosis: Importance As Differential Diagnosis In Skin Diseases. Report of Two Cases | Aida Gonzalez-Carsolio (Mexico)
Poster Session 41: Anaphylaxis
Poster Hall (Cancún Center)
4048
Basophil-Mediated Anaphylaxis Triggered by Drug-Activated Complement Alternative Pathway without Mastocyte's Nor Immunoglobulins Involvement | Giacomo Manfredi (Italy)
4049
Wait At Least 60 Minutes After Eating | Stella Gandhi (US)
4050
First Report of Anaphylactic Shock Caused by the Ingestion of Mite-Infested Flour In Panama | Olga Melcina Barrera de Pino (Panama)
4051
Recurrent Anaphylaxis in Cow's Milk Allergy: What Is Wrong? | Marcela Asanuma Odaira (Brazil)
4052
Epidemiology of Anaphylaxis In Adults Treated In the Emergency Department, of the University Hospital of Monterrey N.L Mexico, During : 2005-2010 | Maricruz Calva (Mexico)
4053
Comprehensive Anaphylaxis Mangement In Schools and Childcare Through Resources, Legislation and Adrenaline Autoinjector Provision | Valerie Noble (Australia)
4054
Buckwheat Pillow Exposure Predisposes to Buckwheat Food-Induced Anaphylaxis | John Kuryan (US)
Poster Session 42: Radiocontrast Media Allergy
Poster Hall (Cancún Center)
4055
Frequency, Characteristics and Outcome of Immediate Hypersensitivity Reactions Due to Iodinated Contrast Media | Thatchai Kampitak (Canada)
4056
Seafood Allergy and Radiocontrast Media: Perceptions of Radiologists and Interventional Cardiologists in Canada | Teresa Pun (Canada)
4057
FREQUENCY of POSITIVE Skin Test for Iodinated Contrast In Outpatient Clinic of Allergy In Rio De Janeiro, Brazil Fábio Kuschnir (Brazil)
4058
Test and Manage Protocol for 841 Patients Requiring Iodinated Contrast Media (ICM) in Pediatrics | Maria Cristina Diaz (Argentina)
Poster Session 43: Hereditary Angioedema
Poster Hall (Cancún Center)
4059
A 26-Year Review of Long-Term Safety of a Human Pasteurized C1 Inhibitor Concentrate | Konrad Bork (Germany)
4060
Efficacy of Icatibant Vs Fresh Frozen Plasma for Attacks of Hereditary Angioedema:Analysis of Indivudual Symptoms by Attack Site | Alicia Lara (Mexico)
4061
Characterization of the Factors Triggering An Edematous Attack in Hereditary Angioedema Dorottya Csuka (Hungary)
4062
Hereditary Angioedema: Report of Ten Mexican Patients At West National Medical Center, in Guadalajara City | Ileana Madrigal (Mexico)
4063
Clinical Features and Outcome of 82 Patients with Hereditary Angioedema Pedro Giavina-Bianchi (Brazil)
4064
Differences of Complement Activation Profile Between Type I and Type II of Hereditary Angioedema Due to C1-inhibitor Deficiency | Dorottya Csuka (Hungary)
Poster Session 44: Urticaria
Poster Hall (Cancún Center)
4065
HLA and Chronic Urticaria with Positive Autologous Serum Skin Test Among Brazilians | Zamir Calamita (Brazil)
4066
CD63 Expression, IL3 Receptor, IgG Autoantibody and Autologous Serum Skin Test Accuracy In Patients with Chronic Urticaria In Brazil | Zamir Calamita (Brazil)
4067
Comparison of the Modified Autologous Serum Skin Test and the CD63 Basophil Activation Test in Chronic Urticaria B. Irinyi1, E. Gyimesi2, E. Garaczi3, Zs. Bata3, K. Hodosi2, M. Zeher2, É. Remenyik1, A. Szegedi1 Department of Dermatology1, 3rd Department o | Beatrix Irinyi (Hungary)
4068
The Frequency of Positivity in Autologous Serum Skin Test in Patients with Chronic Idiopatic Urticaria | Silvio Lima Filho (Brazil)
4069
Eleven Cases of Angioedema with Eosinophilia Treated In A Single Hospital In Japan | Shinichiro Nakachi (Japan)
4070
Chronic Urticaria and Infections | Dr. Nadia Aguilar (Mexico)
4071
Chronic Urticaria Associated with Thyroid Disease | Flor de Guadalupe Peñaloza-González (Mexico)
4072
EPIDEMIOLOGY of Urticaria Cases In A the Allergy SERVICE FROM A Third LEVEL MEDICAL CENTER. SIX YEAR EXPERIENCE Monica martin Del Campo perez (Mexico)
4073
Frequency Of Autoreactivity Demonstrated By Autologous Serum Skin Test in Patients with Chronic Urticaria in The Valley of Mexico During a Period of 8 Years | María Isabel Rojo Gutiérrez (Mexico)
4074
Chronic Idiopathic Urticaria and Neglected Toxocara Infection | Rosanna Qualizza (Italy)
Poster Session 45: Urticaria Treatment
Poster Hall (Cancún Center)
4075
Application of Intravenous Immunoglobulin for Treatment of Chronic Autoimmune Urticaria | Vladimir Alyoshkin (Russia)
Poster Session 46: Urticaria Case Reports
Poster Hall (Cancún Center)
4076
Mucocutaneous Disease As A Presentation of Hereditary Angioedema. Report of 2 Cases | Angelica Alaniz (Mexico)
4077
Plasmapheresis in a Patient with “Refractory” Urticarial Vasculitis Mustafa Gulec (Turkey)
4078
Delayed Diagnosis of Hereditary Angioedema. Case Report Karla Mejia (Mexico)
4079
Urticaria Pigmentosa. Cases Report Karla Mejia (Mexico)
4080
A Case of Chronic Urticaria Complicated by Raoultella Ornithinolytica Urinary Tract Infection, Bronchospasm and Angioedema | Rannakoe Lehloenya (South Africa)
4081
A Case of Idiopathic Recurrent Isolated Orbital Angioedema with Exophthalmos Susan Culverhouse (US)
4082
A Case of Multiple Simultaneous Urticarial Syndromes Refractory to Treatment | Jim Parkerson (US)
4083
Chronic Urticaria As First Sign of Sarcoidosis | María Socorro Pérez-Bustamante (Spain)
4084
Life-Threatening Angioedema without Urticaria (AE-U) | Jacquelynne Corey (US)
4085
URTICARIAL RASH ASSOCIATED WITH CHEST PAIN | Mouna Boulaich (Spain)
Poster Session 47: Autoimmunity Case Reports
Poster Hall (Cancún Center)
4086
Alopecia As a Symptom of Neonatal Lupus: A Report of Case Joselit Torres (Venezuela)
4087
Autoimmune Hepatitis Misdiagnosed As Hepatitis C Responding to Interferon/Ribavirine Therapy | Michal R. Pijak (Slovakia)
4088
Ocular Muscles Myopathy Associated with Autoimmune Thyroiditis. Cases Report | Eugenia Vargas-Camaño (Mexico)
4089
Pulmonary Arterial Hypertension Associated to Antiphospholipid Syndrome In An Infant | Raul Dorbeker (Mexico)
Poster Session 48: Autoimmunity
Poster Hall (Cancún Center)
4090
Autoimmune Diseases and Risk of Stroke | Anita Arsovska (Macedonia)
4091
Clinical Effects of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, on Patients with Autoimmune and Allergic Diseases | Toshio Tanaka (Japan)
4092
Association Between Autoimmune Reactions, Herpes Infection and Severity of Atopic Dermatitis in Children | Pavel Samoylikov (Russia)
4093
Immunomodulatory Effects of Extracorporeal Photochemotherapy in Systemic Sclerosis | Margit Zeher (Hungary)
4094
Comprehensive Analyses of Serum Peptides in Microscopic Polyangiitis | Yukiko Takakuwa (Japan)
4095
Detection of Anti-Nucclear Antibodies (ANA) Used for Diagnostic Approach of Systemic Autoimmune Diseases. Correlation with Double Stranded DNA (DSDNA) and Extractable Nuclear Antigen (ENA) Antibodies Asimoula Koteli (Greece)
4096
The Vasculitis Induced by the Cerebrovascular Coil | Seido Ooka (Japan)
4097
Prevalence of Thyroid Peroxidase Autoantibodies (anti-TPO) in Women with Autoimmune Connective Tissue Diseases (ACTD) Asimoula Koteli (Greece)
4098
Anticardiolipin Antibodies in Patients with Acute Myeloid Leukemia: Prevalence and Clinical Significance | Maryam Ayatollahi (Iran)
Poster Session 49: Allergies in Other Diseases
Poster Hall (Cancún Center)
4099
HLA-B58 Does Not Increase Allopurinol Hypersensitivity Among Patients with Hematologic Malignancy | Jae-Woo Jung (South Korea)
4100
Risk Factors Associated to Mortality In Pediatric Patients with Hemophagocytic Lymphohistiocytosis | Armando Partida-Gaytan (Mexico)
4101
The Clinical and Serological Findings in Patients with Toxocariasis in Korea | Sungjin Choi (South Korea)
4102
Interferon-Gamma Release Assay - Useful Tool for the Diagnosis of Pleural Tuberculosis | Andrea Ondrejkova (Czech Republic)
4103
The Parasite Echinococcus Granulosus Promotes Allergic Response In Human | Manel Amri (Algeria)
4104
Use of Transfer Factor in Patients with Persistent Genital Human Papillomavirus Infection | Blanca Maria Morfin-Maciel (Mexico)
4105
Experimantal Heterophyiasis: Histopathological & Immunological Study | Ahmed Daoud (Egypt)
4106
Chronic Obstructive Pulmonary Disease and Lung Cancer Share Inflammation Pathways | Kostas N. Syrigos (Greece)
4107
Risk Factors of Recurrent Upper Respiratory Infections In Children Under 5 Years. Habana Vieja | Xiomara Lopez Campos (Cuba)
4108
Long Term Asbestos Exposure As A Cause of Eozinophilic Pleural Effusions | Biserka Jovkovska Kaeva (Macedonia)
4109
A Novel Therapeutical Option in Resistant Ganglionar and Cutaneous Tuberculosis | Laura Vidal (Mexico)
Poster Session 50: Asthma Epidemiology
Poster Hall (Cancún Center)
4110
Epidemiology of Asthma Cases In the Allergy Service of A Third Level Medical Center. Six Year Expirience | Luis Rafael Sanchez-Gallardo (Mexico)
4111
Latin America Asthma Insight and Management (LA AIM): A Survey of Asthma Patients in 5 Latin American Locales | Sandra González-Díaz (Mexico)
4112
Understanding of Asthma Terminology by Patients Interviewed in the Latin America Asthma Insight and Management (LA AIM) Survey | Jose Jardim (Brazil)
4113
Asthma Management in Latin America: Learnings From the Latin America Asthma Insight and Management (LA AIM) Survey of Patients | Jorge Maspero (Argentina)
4114
Project for Prevention & Control of Asthma and Allergic Diseases in Korea | Eun Hee Chung (South Korea)
4115
Asthma In the CIS-Region: The Prevalence and Peculiarities of the Course | Tatiana Slavyanskaya (Russia)
4116
Asthma In the Elderly: A Mexican Point of View | Maria Rosario Perez-Chavira (Mexico)
4117
Control of Asthma and Its Relationship to Quality of Life in Adolescents Antônio Carlos Pastorino (Brazil)
4118
The Leukotriene C4 Synthase (A-444C) Promoter Polymorphism in Venezuelan Individuals with Asthma | Ingrid Quintana Quintero (Venezuela)
4119
Allergic Disorders Prevented by Helicobacter Pylori Colonization | Olf Herbarth (Germany)
Poster Session 51: Quality of Life Measures in Asthma and Allergic Diseases
Poster Hall (Cancún Center)
4120
Management of Twenty-Five Pediatric Patients with Hereditary Angioedema (HAE) Undergoing Home Treatment- A Clinical Surveillance Program | Inmaculada Martinez-Saguer (Germany)
4121
The Impact of Nasal Allergies: Results From the Allergies Surveys in America, Asia Pacific, Latin America, and Middle East | Michael S. Blaiss (US)
4122
The Impact of Nasal Polyposis on Quality of Life Using the EQ-5D Health Profile | Isam Alobid (Spain)
4123
Predictors Affecting the Quality of Life of Patients with Bronchial Asthma Andrzej Fal (Poland)
4124
Correlation Between Severity of Allergic Rhinitis and Impairment of Quality of Life in Allergic Adolescents | Eric Martinez Infante (Mexico)
4125
Chronic Urticaria Quality of Life Questionnaire (Cu-Q2 oL) and Urticaria Activity Score (UAS) | Dr. Nadia Aguilar (Mexico)
4126
The Relationship of Asthma Impairment Determined by Psychometric Tools to Subsequent Asthma Exacerbations Felicia Allen-Ramey (US)
Poster Session 52: Health Outcomes for Asthma
Poster Hall (Cancún Center)
4127
Developing An Adult Asthma Adherence Questionnaire (AAAQ) | Andrew Weinstein (US)
4128
Associations Between Self-Reported Adherence to Asthma Anti-Inflammatory Therapy and Risk Factors for Non-Adherence (NA) in Pediatric Patients | Andrew Weinstein (US)
4129
Inability of Medical Students to Use of Three Types of Inhaler | Jae-Won Jeong (South Korea)
4130
State of Asthma Education and Management in Urban Medical Residency Training Programs | John Kuryan (US)
4131
Impact of Providing Physical Education Teachers with Information about Asthma When Training Children and Adolescents WithThis Disorder | Dania Fabré (Cuba)
4132
Asthma Knowledge Among Parents and/or Caregivers of Asthmatic Children Attending A Practical Allergy Course | Eunice Sandoval-Ramírez (Mexico)
4133
Ezhengtricity © 2010: A Free Novel Way to Confidentially Administer, Track, Receive and Score Medical Questionnaires Instantly James Baraniuk (US)
4134
Usefulness of Asthma Control Test Questionnaire, FEV1 and Exhaled Nitric Oxide Level(FeNO) for the Clinical Assessment of Elderly Asthma | Yong Ho Roh (South Korea)
4135
Systematic Review of the Recommendations on the Prevention of Allergic Manifestations in Children Joerg Spieldenner (Switzerland)
4136
The Relationship Between Emotional Cognition and the Symptom Gap in Patients with Bronchial Asthma: The Effects of Alexithymia and Empathy | Sonomi Nakajima (Japan)
4137
Asthma control аnd quality of care of adult asthma patients in primary health care facilities in Saint- Petersburg, Russia | Alexander Emelyanov (Russia)
Poster Session 53: Severe and Fatal Asthma
Poster Hall (Cancún Center)
4138
Severe Asthma: Report of Five Clinical Cases At West National Medical Center, IMSS in Guadalajara City, Mexico | Carlos Torres-Lozano (Mexico)
4139
Factores De Riesgo De Muerte Por Asma Bronquial En Centro Habana En El Período Comprendido Entre 1995-2010 | Adelquis Guerrero (Cuba)
4140
Dolichyl Phosphate Dependent Mechanism of Exacerbations In Asthma: P-Glycoprotein Overexpression and E-Cadherin Loss | Galina Kuznecova (Latvia)
4141
Distribution of Asthma Mortality in Various Districts of Salvador, Brazil | Carolina Souza-Machado (Brazil)
4142
Geographical Distribution of Deaths From Asthma in Salvador, Brazil (2000-2009) | Carolina Souza-Machado (Brazil)
4143
Measurement of Long-Acting Natriuretic Peptide (LANP) in Exacerbation of Asthma | Michel Alkhalil (US)
4144
Is It Really Difficult-to-Treat Asthma? Don't Forget Other Causes of Wheeze A. Fusun Kalpaklioglu (Turkey)
4145
Sensitization profile in severe asthma Barbara Rogala (Poland)

12:45 - 14:15

Poster Symposium 4: Immunotherapy
Bacalar (Cancún Center)
 Chairpersons: Harold Nelson (US) and Stephen Durham (United Kingdom)
12:45 - 13:30
Poster Viewing
13:30 - 00:00
4146: AAAAI Survey On Immunotherapy Practice Patterns Concerning Dosing, Dose-Adjustment After Missed Doses and Duration of Immunotherapy | Désirée Larenas Linnemann (Mexico)
13:30 - 00:00
4147: Development of A National Guideline On Skin Testing and Immunotherapy | Désirée Larenas Linnemann (Mexico)
13:30 - 00:00
4148: Efficacy of Mite Sublingual Immunotherapy In 130 Children with Atopic Dermatitis | Jianping Tang (China)
13:30 - 00:00
4149: Down Regulation of Allergic Inflammation with Allergy Vaccine Timpol In A Murine Model of Asthma | Igor Shilovskiy (Russia)
13:30 - 00:00
4150: Clinical Efficacy and Mucosal/Systemic Antibody Response Changes After Sublingual Immunotherapy in Mite-Allergic Children: A Randomized Double-Blind, Placebo-Controlled Study in Brazil Ernesto Taketomi (Brazil)
13:30 - 00:00
4151: Treatment Satisfaction with Sublingual Immunotherapy in a Real-Life Setting | Meike Hadler (Germany)
13:30 - 00:00
4152: Long Term Follow-up After Completion of Inhalant Allergen-Specific Subcutaneous Immunotherapy Jacquelynne Corey (US)
13:30 - 00:00
4153: Long-Term Clinical Efficacy of Immunotherapy in Rhino-Conjunctivitis with Pollen Extract | Carlos Nunes (Portugal)
13:30 - 00:00
4154: IgE/IgG4 Ratio As a Possible Surrogate Marker of Clinical Efficacy During Allergen-Specific Immunotherapy with House Dust Mite Vaccines | Alexis Labrada (Cuba)
13:30 - 00:00
4155: Allergy Training and Immunotherapy in Latin America: How Survey-results lead to a Regional Overview | R Maximiliano Gomez (Argentina)
13:30 - 00:00
4156: Clinical Effects of Immunotherapy in Patients with Allergic Disease in the National Institute of Respiratory Diseases | Ma del Rosario Gonzalez Galarza (Mexico)
13:30 - 00:00
4157: Approach of Paediatric Allergists to Allergen Immunotherapy in Severe Persistent Allergic Rhinitis | Alessandro Fiocchi (Italy)
13:30 - 00:00
4158: Compliance and Persistence to Grass Immunotherapy Treatment Is Comparable for Allergy Immunotherapy Tablets and Subcutaneous Immunotherapy: A Swedish Registry Study Simon Lawton (Denmark)
Oral Abstract Session 24: Atopic Dermatitis 2
Gran Cancún 1 (Cancún Center)
 Chairpersons: Elizabeth Estrada Reyes (Mexico) and Mona Al-Ahmad (Kuwait)
12:45 - 13:00
4159: The Risk of Atopic Dermatitis in Children Exposed to Pets During Pregnancy | Neetu Vasu (US)
13:00 - 13:15
4160: Economic Analyses of Partially Hydrolyzed Infant Formulas in Prevention of Atopic Dermatitis: Results From 5 European Countries Joerg Spieldenner (Switzerland)
13:15 - 13:30
4161: Prevalence and Associated Risk Factors for Atopic Dermatitis Symptoms in Mexican Children | Eunice Sandoval-Ramírez (Mexico)
13:30 - 13:45
4162: Involvement of Human Histamine N-Methyltransferase Gene Polymorphisms in Susceptibility to Atopic Dermatitis in Korean Children Yong Ju Lee (South Korea)
13:45 - 14:00
4163: Circadian Regulation of Scratching Behavior in NC/Tnd Mice, a Mouse Model for Human Atopic Dermatitis | Keitaro Ohmori (Japan)
14:00 - 14:15
4164: Metallic Soap Aggravates Skin Conditions in Patients with Atopic Dermatitis and a Mouse Model for Human Atopic Dermatitis, NC/Tnd Mice | Akane Tanaka (Japan)
Oral Abstract Session 25: Childhood Asthma and Allergies
Gran Cancún 2 (Cancún Center)
 Chairpersons: S.G.O. Johansson and Mika Mäkelä
12:45 - 13:00
4165: The Allergic March Resolved At Allergen Component Level | Giovanni Melioli (Italy)
13:00 - 13:15
4166: Prevalence of Wheezing and Risk Factors Associated to Wheezing in Infants in the First Year of Life, Cuiabá, MT, Brazil | Lillian Sanchez Lacerda Moraes (Brazil)
13:15 - 13:30
4167: Specific IgE Sensitisation In A Six-Year Old Infant Cohort In New Zealand | Rob Siebers (New Zealand)
13:30 - 13:45
4168: Risk Factors Associated to Wheezing In Mexican Children. A Multicentric ISAAC-Based Survey Study | Armando Partida-Gaytan (Mexico)
13:45 - 14:00
4169: Association Between Eosinophil Apoptosis in Induced Sputum and Asthma Severity in Children | Alla Nakonechna (United Kingdom)
14:00 - 14:15
4170: Antibiotics but Not Paracetamol Reduce the Risk for Recurrent Wheezing in Infants | Herberto Jose Chong Neto (Brazil)
Oral Abstract Session 26: Cytokines and Chemokines
Gran Cancún 3 (Cancún Center)
 Chairpersons: Francesca Levi-Schaffer (Israel) and Andrew Wardlaw (United Kingdom)
12:45 - 13:00
4171: Hypoxia-Inducible Factor 1 (HIF-1) Transcription Is a “Signalling Driver” for Allergic Inflammation, Host Innate Immune Defence and Leukaemia Progression | Vadim Sumbayev (United Kingdom)
13:00 - 13:15
4172: Keratinocytic Thymic Stromal Lymphopoietin Plays An Important Role in Epicutaneous Sensitization and the Atopic March | Juan Manuel Leyva Castillo (France)
13:15 - 13:30
4173: Pivotal Role of Intestinal Interleukin-17-Producing Gammadeltat Cells In the Food Allergy | Ryusuke Nakagawa (Japan)
13:30 - 13:45
4174: Effect of Formoterol on Eosinophil Trans-Basement Migration Induced by Interleukin-8-Stimulated Neutrophils | Akiko Kawashima (Japan)
Oral Abstract Session 27: Drug Allergy
Gran Cancún 4 (Cancún Center)
 Chairpersons: David Khan (US) and Luis Felipe Chiaverini Ensina (Brazil)
12:45 - 13:00
4175: Characteristics of Liver Injury in Drug-Induced Systemic Hypersensitivity Reactions | Chan Sun Park (South Korea)
13:00 - 13:15
4176: Outcomes of Reintroducing Antituberculous Drugs Following Cutaneous Adverse Drug Reactions | Rannakoe Lehloenya (South Africa)
13:15 - 13:30
4177: Penicillin - Diagnosis of Allergy | Janni Hjortlund (Denmark)
13:30 - 13:45
4178: Clinical Features and Risk Factors of Oxaliplatin Hypersensitivity in Koreans Yoon-Seok Chang (South Korea)
13:45 - 14:00
4179: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): What We Still Have to Learn? | Luciana Kase Tanno (Brazil)
Oral Abstract Session 28: Food Allergy
Gran Cancún 5 (Cancún Center)
 Chairpersons: Kyu-Earn Kim (South Korea) and Sami Bahna (US)
12:45 - 13:00
4180: Glutathione Exposed Sequential Epitopes of Ovomucoid Are Relevant for Persistent Egg-Allergic Patients Tamar Kinaciyan (Austria)
13:00 - 13:15
4181: The Choice of Hypoallergens for Fish and Peach to Develop Food Allergy Specific Immunotherapy (The FAST Project) | Laurian Zuidmeer-Jongejan (Netherlands)
13:15 - 13:30
4182: IFN-ã Induces Milk Allergen-Specific IL-10-Producing Regulatory B Cells in Non -IgE Mediated Milk Allergy | Jae Ho Lee Sr. (South Korea)
13:30 - 13:45
4183: Analysis of IgE, IgE RAST Value and Prick Test in Wheat or Hen's Egg-Allergy Infants Treated with Slow Specific Oral Tolerance Induction Therapy | Takeshi Noma (Japan)
13:45 - 14:00
4184: Efficacy of Slow Oral Immunotherapy for Cow's Milk Allergy | Kiyotake Ogura (Japan)
14:00 - 14:15
4185: Factors Associated with Development of Food Allergy in Liver-Transplanted Children | Tetsuo Shoda (Japan)
Oral Abstract Session 29: Hymenoptera Allergy
Cozumel 2 (Cancún Center)
 Chairpersons: James Tracy (US) and Mubeccel Akdis (Switzerland)
12:45 - 13:00
4186: Clinical Features and Diagnostic Value of Specific IgE to Component Allergen in Bee Venom Allergy in Korea | Yoo Seob Shin (South Korea)
13:00 - 13:15
4187: Is Basophil Specific Response to Hymenoptera Venom Related to T Regulatory Cells? | Petr Kucera (Czech Republic)
13:15 - 13:30
4188: Improving the Diagnosis of Hymenoptera Venom Allergy: Component Resolved Diagnosis | Liliana Cifuentes (Germany)
13:30 - 13:45
4189: Efficacy of Venom Immunotherapy Given Every 3 or 4 MONTHS. A DIRECT Prospective COMPARISON with the Conventional REGIMEN | Livio Simioni (Italy)
13:45 - 14:00
4190: SERUM CTLA-4 and IL-10 In Hymenoptera Venom Immunotherapy: Equivalence of DIFFERENT INDUCTION Regimens | Anna Maria Riccio (Italy)
14:00 - 14:15
4191: Purification of the Allergenic Protein Hyaluronidase From the Venom of Social Wasp Polybia Paulista (Hymenoptera: Vespidae) | Débora Laís Justo Jacomini (Brazil)
Oral Abstract Session 30: Immunobiology of Allergens
Isla Mujeres (Cancún Center)
 Chairpersons: Barbara Gepp (Austria) and Christian Radauer (Austria)
12:45 - 13:00
4192: High Immunogenicity of the Allergen Phl p 5 Expressed in Transgenic Mice As a Membrane-Anchored Protein | Andreas Farkas (Austria)
13:00 - 13:15
4193: Specific Recognition of the Major Birch Pollen Allergen Bet v 1 Programs Dendritic Cells to Induce Either Th2 or Tolerogenic Responses | Ursula Smole (Austria)
13:15 - 13:30
4194: Recombinant Scfv Antibodies for IgE Epitope Mapping and Detection of Parvalbumins | Merima Bublin (Austria)
13:30 - 13:45
4195: Bet v 1-Specific T-Cell Receptor/Forkhead Box Protein 3 Transgenic T-Cells Suppress Bet v 1-Specific T-Cell Effector Function in An Activation-Dependent Manner | Klaus Schmetterer (Austria)
13:45 - 14:00
4196: Grass Pollen Allergen-Induced Surface Expression of CD203c, CD63 and CD107a on CRTH2+ Basophils: Novel Biomarkers for Monitoring Efficacy of Allergen-Specific Immunotherapy | Mohamed Shamji (United Kingdom)
14:00 - 14:15
4197: Specific IgE and IgG Binding to Allergoids of Phleum Pratense | Barbara Cases (Spain)
Oral Abstract Session 31: Mechanisms of Asthma and Allergic Inflammation
Tulum (Cancún Center)
 Chairpersons: Homer Boushey (US) and Elliot Israel (US)
12:45 - 13:00
4198: Heterogeneity of Allergen Epitope-Specific CD4+ T Cells Responses: Steps Toward Optimal Composition for Peptide-Based Immunotherapy | Erik Wambre (US)
13:00 - 13:15
4199: The Association Between Mast Cells and Remodelling of the Small Airways in Chronic Asthma | Kenneth Snibson (Australia)
13:15 - 13:30
4200: Creation of a Humanized Model for Respiratory Allergy Using a Human Mugwort-Specific T-Cell Receptor and HLA-DR1 | Alina Neunkirchner (Austria)
13:30 - 13:45
4201: Eosinophils Enhance Airway Smooth Muscle Cell Proliferation Via the Release of Cysteinyl Leukotrines | Rabih Halwani (Saudi Arabia)
13:45 - 14:00
4202: Colour Change In the Human Histamine Wheal; A Sign of Desensitized Histamine Vasoconstrictory Receptors | Lars Malm (Sweden)
14:00 - 14:15
4203: Involvement of the Hypoxia-Inducible Factor-1 Transcription Complex in the Inflammatory Responses of Human Mast Cells and Basophils Vadim Sumbayev (United Kingdom)
Oral Abstract Session 32: Primary Immunodeficiency
Xcaret (Cancún Center)
 Chairpersons: Hani Ababneh (Jordan) and Charlotte Cunningham-Rundles (US)
12:45 - 13:00
4204: Mycobacterial Infections In Children with Chronic Granulomatous Disease | Saul Lugo-Reyes (Mexico)
13:00 - 13:15
4205: Increased Pro-Inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-Linked Agammaglobulinemia | Maria Edith Gonzalez Serrano (Mexico)
13:15 - 13:30
4206: Hypogammaglobulinemia in a Boy: Consider Also X- Linked Lymphoproliferative Disease | Luisa Gamez (Mexico)
13:30 - 13:45
4207: Transmission Pattern and Carriers Identification in Male Patients with Chronic Granulomatous Disease | Blancas-Galicia Lizbeth (Mexico)
13:45 - 14:00
4207A: Genetic Association Study of the IgE Immunodeficiency in Mexican Population | Jose Augusto Malpica Cruz (Mexico)
14:00 - 14:15
4208: CD21-/Low B Cells Are Increased in Both Common Variable Immune Deficiency (CVID) and Specific Antibody Deficiency (SAD) | Araceli Elizalde (US)
Oral Abstract Session 33: Rhinitis Treatment 2
Costa Maya 1 (Cancún Center)
 Chairpersons: Joaquim Mullol (Spain) and James Baraniuk (US)
12:45 - 13:00
4209: Patterns of Initiation and Adherence to De Novo Allergen-Specific Immunotherapy Among Adults and Children with Newly-Diagnosed Allergic Rhinitis: Findings From Research Jointly Funded by the AAAAI and ACAAI | Cheryl Hankin (US)
13:00 - 13:15
4210: Effect of Simvastatin on Transforming Growth Factor Beta-1-Induced Myofibroblast Differentiation and Collagen Production in Nasal Polyp-Derived Fibroblasts | Il-Ho Park (South Korea)
13:15 - 13:30
4211: Onset of Action of MP29-02 in the Treatment of Seasonal Allergic Rhinitis | Jonathan Bernstein (US)
13:30 - 13:45
4212: MP29-02 in the Treatment of Nasal Symptoms of Seasonal Allergic Rhinitis | William Wheeler (US)
13:45 - 14:00
4213: A 26-Week Study Evaluating the Safety and Efficacy of Ciclesonide Hydrofluoralkane Nasal Aerosol in Subjects with Perennial Allergic Rhinitis John Karafilidis (US)
14:00 - 14:15
4214: Omalizumab Improves Asthma but Not Nasal Symptoms in Japanese Patients with Severe Allergic Asthma and Rhinitis | Fuyumi Nishihara (Japan)
Oral Abstract Session 34: Allergen Immunotherapy 2
Costa Maya 2 (Cancún Center)
 Chairpersons: Lars Jacobsen (Denmark) and Guillermo Salamanca (Spain)
12:45 - 13:00
4215: Efficacy and Safety of Ragweed Allergy Immunotherapy Tablet in Multisensitized North American Adults: Preliminary Findings | Peter Creticos (US)
13:00 - 13:15
4216: Comparison of Efficacy and Safety of A Depigmented Polymerized Allergen Extract of Grass and Birch with Placebo In Patients with Type-I Allergic Rhinoconjunctivitis | Angelika Sager (Germany)
13:15 - 13:30
4217: Allergenic Composition of Polymerized Allergen Extracts of Betula Verrucosa, Dermatophagoides Pteronyssinus and Phleum Pratense | Enrique Fernandez-Caldas (Spain)
13:30 - 13:45
4218: A Proteomic Style Approach to Characterise a Grass Mix Product Reveals Potential Immunotherapeutic Benefit Alan Bullimore (United Kingdom)
13:45 - 14:00
4219: Seasonal Vs. Symptom-Based Evaluation of A Depigmented Grass-Birch Allergoid | Oliver Pfaar (Germany)
14:00 - 14:15
4220: Efficacy and Tolerability of HDM Injective Immunotherapy with Monomeric Allergoid | Enrico Compalati (Italy)